Rang and Dale Pharmacology Flashcards.pdf

6,486 views 594 slides Feb 21, 2024
Slide 1
Slide 1 of 657
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70
Slide 71
71
Slide 72
72
Slide 73
73
Slide 74
74
Slide 75
75
Slide 76
76
Slide 77
77
Slide 78
78
Slide 79
79
Slide 80
80
Slide 81
81
Slide 82
82
Slide 83
83
Slide 84
84
Slide 85
85
Slide 86
86
Slide 87
87
Slide 88
88
Slide 89
89
Slide 90
90
Slide 91
91
Slide 92
92
Slide 93
93
Slide 94
94
Slide 95
95
Slide 96
96
Slide 97
97
Slide 98
98
Slide 99
99
Slide 100
100
Slide 101
101
Slide 102
102
Slide 103
103
Slide 104
104
Slide 105
105
Slide 106
106
Slide 107
107
Slide 108
108
Slide 109
109
Slide 110
110
Slide 111
111
Slide 112
112
Slide 113
113
Slide 114
114
Slide 115
115
Slide 116
116
Slide 117
117
Slide 118
118
Slide 119
119
Slide 120
120
Slide 121
121
Slide 122
122
Slide 123
123
Slide 124
124
Slide 125
125
Slide 126
126
Slide 127
127
Slide 128
128
Slide 129
129
Slide 130
130
Slide 131
131
Slide 132
132
Slide 133
133
Slide 134
134
Slide 135
135
Slide 136
136
Slide 137
137
Slide 138
138
Slide 139
139
Slide 140
140
Slide 141
141
Slide 142
142
Slide 143
143
Slide 144
144
Slide 145
145
Slide 146
146
Slide 147
147
Slide 148
148
Slide 149
149
Slide 150
150
Slide 151
151
Slide 152
152
Slide 153
153
Slide 154
154
Slide 155
155
Slide 156
156
Slide 157
157
Slide 158
158
Slide 159
159
Slide 160
160
Slide 161
161
Slide 162
162
Slide 163
163
Slide 164
164
Slide 165
165
Slide 166
166
Slide 167
167
Slide 168
168
Slide 169
169
Slide 170
170
Slide 171
171
Slide 172
172
Slide 173
173
Slide 174
174
Slide 175
175
Slide 176
176
Slide 177
177
Slide 178
178
Slide 179
179
Slide 180
180
Slide 181
181
Slide 182
182
Slide 183
183
Slide 184
184
Slide 185
185
Slide 186
186
Slide 187
187
Slide 188
188
Slide 189
189
Slide 190
190
Slide 191
191
Slide 192
192
Slide 193
193
Slide 194
194
Slide 195
195
Slide 196
196
Slide 197
197
Slide 198
198
Slide 199
199
Slide 200
200
Slide 201
201
Slide 202
202
Slide 203
203
Slide 204
204
Slide 205
205
Slide 206
206
Slide 207
207
Slide 208
208
Slide 209
209
Slide 210
210
Slide 211
211
Slide 212
212
Slide 213
213
Slide 214
214
Slide 215
215
Slide 216
216
Slide 217
217
Slide 218
218
Slide 219
219
Slide 220
220
Slide 221
221
Slide 222
222
Slide 223
223
Slide 224
224
Slide 225
225
Slide 226
226
Slide 227
227
Slide 228
228
Slide 229
229
Slide 230
230
Slide 231
231
Slide 232
232
Slide 233
233
Slide 234
234
Slide 235
235
Slide 236
236
Slide 237
237
Slide 238
238
Slide 239
239
Slide 240
240
Slide 241
241
Slide 242
242
Slide 243
243
Slide 244
244
Slide 245
245
Slide 246
246
Slide 247
247
Slide 248
248
Slide 249
249
Slide 250
250
Slide 251
251
Slide 252
252
Slide 253
253
Slide 254
254
Slide 255
255
Slide 256
256
Slide 257
257
Slide 258
258
Slide 259
259
Slide 260
260
Slide 261
261
Slide 262
262
Slide 263
263
Slide 264
264
Slide 265
265
Slide 266
266
Slide 267
267
Slide 268
268
Slide 269
269
Slide 270
270
Slide 271
271
Slide 272
272
Slide 273
273
Slide 274
274
Slide 275
275
Slide 276
276
Slide 277
277
Slide 278
278
Slide 279
279
Slide 280
280
Slide 281
281
Slide 282
282
Slide 283
283
Slide 284
284
Slide 285
285
Slide 286
286
Slide 287
287
Slide 288
288
Slide 289
289
Slide 290
290
Slide 291
291
Slide 292
292
Slide 293
293
Slide 294
294
Slide 295
295
Slide 296
296
Slide 297
297
Slide 298
298
Slide 299
299
Slide 300
300
Slide 301
301
Slide 302
302
Slide 303
303
Slide 304
304
Slide 305
305
Slide 306
306
Slide 307
307
Slide 308
308
Slide 309
309
Slide 310
310
Slide 311
311
Slide 312
312
Slide 313
313
Slide 314
314
Slide 315
315
Slide 316
316
Slide 317
317
Slide 318
318
Slide 319
319
Slide 320
320
Slide 321
321
Slide 322
322
Slide 323
323
Slide 324
324
Slide 325
325
Slide 326
326
Slide 327
327
Slide 328
328
Slide 329
329
Slide 330
330
Slide 331
331
Slide 332
332
Slide 333
333
Slide 334
334
Slide 335
335
Slide 336
336
Slide 337
337
Slide 338
338
Slide 339
339
Slide 340
340
Slide 341
341
Slide 342
342
Slide 343
343
Slide 344
344
Slide 345
345
Slide 346
346
Slide 347
347
Slide 348
348
Slide 349
349
Slide 350
350
Slide 351
351
Slide 352
352
Slide 353
353
Slide 354
354
Slide 355
355
Slide 356
356
Slide 357
357
Slide 358
358
Slide 359
359
Slide 360
360
Slide 361
361
Slide 362
362
Slide 363
363
Slide 364
364
Slide 365
365
Slide 366
366
Slide 367
367
Slide 368
368
Slide 369
369
Slide 370
370
Slide 371
371
Slide 372
372
Slide 373
373
Slide 374
374
Slide 375
375
Slide 376
376
Slide 377
377
Slide 378
378
Slide 379
379
Slide 380
380
Slide 381
381
Slide 382
382
Slide 383
383
Slide 384
384
Slide 385
385
Slide 386
386
Slide 387
387
Slide 388
388
Slide 389
389
Slide 390
390
Slide 391
391
Slide 392
392
Slide 393
393
Slide 394
394
Slide 395
395
Slide 396
396
Slide 397
397
Slide 398
398
Slide 399
399
Slide 400
400
Slide 401
401
Slide 402
402
Slide 403
403
Slide 404
404
Slide 405
405
Slide 406
406
Slide 407
407
Slide 408
408
Slide 409
409
Slide 410
410
Slide 411
411
Slide 412
412
Slide 413
413
Slide 414
414
Slide 415
415
Slide 416
416
Slide 417
417
Slide 418
418
Slide 419
419
Slide 420
420
Slide 421
421
Slide 422
422
Slide 423
423
Slide 424
424
Slide 425
425
Slide 426
426
Slide 427
427
Slide 428
428
Slide 429
429
Slide 430
430
Slide 431
431
Slide 432
432
Slide 433
433
Slide 434
434
Slide 435
435
Slide 436
436
Slide 437
437
Slide 438
438
Slide 439
439
Slide 440
440
Slide 441
441
Slide 442
442
Slide 443
443
Slide 444
444
Slide 445
445
Slide 446
446
Slide 447
447
Slide 448
448
Slide 449
449
Slide 450
450
Slide 451
451
Slide 452
452
Slide 453
453
Slide 454
454
Slide 455
455
Slide 456
456
Slide 457
457
Slide 458
458
Slide 459
459
Slide 460
460
Slide 461
461
Slide 462
462
Slide 463
463
Slide 464
464
Slide 465
465
Slide 466
466
Slide 467
467
Slide 468
468
Slide 469
469
Slide 470
470
Slide 471
471
Slide 472
472
Slide 473
473
Slide 474
474
Slide 475
475
Slide 476
476
Slide 477
477
Slide 478
478
Slide 479
479
Slide 480
480
Slide 481
481
Slide 482
482
Slide 483
483
Slide 484
484
Slide 485
485
Slide 486
486
Slide 487
487
Slide 488
488
Slide 489
489
Slide 490
490
Slide 491
491
Slide 492
492
Slide 493
493
Slide 494
494
Slide 495
495
Slide 496
496
Slide 497
497
Slide 498
498
Slide 499
499
Slide 500
500
Slide 501
501
Slide 502
502
Slide 503
503
Slide 504
504
Slide 505
505
Slide 506
506
Slide 507
507
Slide 508
508
Slide 509
509
Slide 510
510
Slide 511
511
Slide 512
512
Slide 513
513
Slide 514
514
Slide 515
515
Slide 516
516
Slide 517
517
Slide 518
518
Slide 519
519
Slide 520
520
Slide 521
521
Slide 522
522
Slide 523
523
Slide 524
524
Slide 525
525
Slide 526
526
Slide 527
527
Slide 528
528
Slide 529
529
Slide 530
530
Slide 531
531
Slide 532
532
Slide 533
533
Slide 534
534
Slide 535
535
Slide 536
536
Slide 537
537
Slide 538
538
Slide 539
539
Slide 540
540
Slide 541
541
Slide 542
542
Slide 543
543
Slide 544
544
Slide 545
545
Slide 546
546
Slide 547
547
Slide 548
548
Slide 549
549
Slide 550
550
Slide 551
551
Slide 552
552
Slide 553
553
Slide 554
554
Slide 555
555
Slide 556
556
Slide 557
557
Slide 558
558
Slide 559
559
Slide 560
560
Slide 561
561
Slide 562
562
Slide 563
563
Slide 564
564
Slide 565
565
Slide 566
566
Slide 567
567
Slide 568
568
Slide 569
569
Slide 570
570
Slide 571
571
Slide 572
572
Slide 573
573
Slide 574
574
Slide 575
575
Slide 576
576
Slide 577
577
Slide 578
578
Slide 579
579
Slide 580
580
Slide 581
581
Slide 582
582
Slide 583
583
Slide 584
584
Slide 585
585
Slide 586
586
Slide 587
587
Slide 588
588
Slide 589
589
Slide 590
590
Slide 591
591
Slide 592
592
Slide 593
593
Slide 594
594
Slide 595
595
Slide 596
596
Slide 597
597
Slide 598
598
Slide 599
599
Slide 600
600
Slide 601
601
Slide 602
602
Slide 603
603
Slide 604
604
Slide 605
605
Slide 606
606
Slide 607
607
Slide 608
608
Slide 609
609
Slide 610
610
Slide 611
611
Slide 612
612
Slide 613
613
Slide 614
614
Slide 615
615
Slide 616
616
Slide 617
617
Slide 618
618
Slide 619
619
Slide 620
620
Slide 621
621
Slide 622
622
Slide 623
623
Slide 624
624
Slide 625
625
Slide 626
626
Slide 627
627
Slide 628
628
Slide 629
629
Slide 630
630
Slide 631
631
Slide 632
632
Slide 633
633
Slide 634
634
Slide 635
635
Slide 636
636
Slide 637
637
Slide 638
638
Slide 639
639
Slide 640
640
Slide 641
641
Slide 642
642
Slide 643
643
Slide 644
644
Slide 645
645
Slide 646
646
Slide 647
647
Slide 648
648
Slide 649
649
Slide 650
650
Slide 651
651
Slide 652
652
Slide 653
653
Slide 654
654
Slide 655
655
Slide 656
656
Slide 657
657

About This Presentation

pharmacology


Slide Content

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&.g hn dhGw toAsc‚
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis

R&D 7e7C&h24&CD,Cp3
R&D 7e7C&h24&CD,Cp3
0&D ,e;C&h
H5;H;8pH &C&
0&D ,e;C&h
H5;H;8pH &C&
-5,9,e;3
-5,9,e;3
H5;4&C
)bpmwmti 0;5H 7C&h2e7,9;5H 7C&h
yklgitmgldstioa,m isti
vit.mgea,mgniw
fdbpbck.
BGI
)Tr
fs..kia bcbui
)m,s,ilnsxiazamgaGaB
lbstab•igitn
vlstmndbpbcs,angb,n
tikgmt
(tnigtikgmtast
 mg.bpadmgt
rmgldstioa sbcmgldstio
yklgitmgldstioa,m isti
Bindisi toaht
•m,k.a,igkpik.

ReaoftFrtiidea pitf (.r etpr.Fdahon Fdoe )Aoloudr frpcg e.raroFa-uoetmy(t dtu bFtio
Reductuioun furupa hude.uatuiounafuru(F
Reduction of neuropathic pain. (For antidepressant action see set 24).Reducti
Analgesic action of antidepressants is mainly due to inhibition of the opening of neuronal 
voltage-gated Na

channels (Na
v
 1.7 subtype) rather than to inhibition of monoamine reuptake. Na
+
 
channel block reduces pain transmission from site of nerve injury. 
onR
Postherpetic neuralgia, diabetic peripheral neuropathy, neuropathic cancer pain. futuerfpaih
Sedation (antihistamine action, less with nortriptyline). Blurred vision, dry mouth, constipation,
urinary retention (antimuscarinic action). Postural hypotension (R
1
-adrenoceptor antagonism).
Overdose potentially fatal due to cardiac dysrhythmia, severe hypotension, seizure and CNS
depression. Increased risk of suicide in young patients. 
R.(hFihphshedi
Oral administration. Hepatic P450 metabolism (nortriptyline is a metabolite of amitriptyline).
T
0.5
 12–24h.
R2i4)uidF24Aful

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&Goboh,nfdnAscƒ
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
prexrfn,TtmmtInb,fuNcrmbdn,rS
srSNr,hn,A
,bether,reAnN
n,cnGnInb,
srSNr,hn,A
SrebIb,reAnNu
r,drRctgn,reAnN
n,cnGnInb,
prvebRtIcnNfRtn,
CgvItmtIru
SvGSIt,Nrfl
lebSItAgt,hn,S
•,R,
r,drRctgn,
fRn,tgfNbeh
R&DCh
lrenRcrei

Pethidine, fentanyl
Pethidine, fentanyl
Methadone,
propoxyphene
Methadone,
propoxyphene
Tramadol
Tramadol
Ibuprofen
Naloxone Morphine, diamorphine,
buprenorphine, codeine
Sensory cortex
Thalamus
PAG
NRM
Tissue damage
Nociceptive C or A B
pain aferent
Spinothalamic tract
neuron
Interneuron in
dorsal horn
Morphine, diamorphine,
buprenorphine, codeine
Amitriptyline
Carbamazepine
Locus ceruleus

G-protrerinNCiN5pt n5b5ordtgdwastbim5lrpr5ei1G-prot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
7
ibn5oopdei -CsiToeTlp

????
??
???
inG
? ??
?? ?
???????? ?
? ?? ????
NCrtr-5CHTe 
? ????
??

Gbd ge H w -pe
???
?? ??
??????
?
?
GaesmrepgaslCr1
? ?
?
7
? ?
?
7
?
7
?
7
?
7
α
β β

To

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o

G-protrerinNCiN5pt 35b5ordtgdwastoil-4wm5lrpr5ei6td-m5lrpr5ei1HT -btot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
b
ibn5oopdei -CsiToeTlp
ffmm)uffmm)f/RfT)fx
T/mu••(u•••m/TxP
tnpidC3p-iN•iTob-p5epeiTCoTe5tTCoiC itnpi3p5ad i25eTbidCb5d
5o5petnptTbi••-•g
inG
€ ‚
ƒ   
NCrtr-5CHTe 
­ „ƒ …­
-CNTr5b5Topidpeeib5-lTCtC…Tbg•
Gbd ge H w -pe
†  ‡ˆ‰ 
   † 
­†
‰gˆ
iŠ‹Œng
GaesmrepgaslCr1
Ž ‘

7
Ž 
wi7i•
7
iiiiiw•
7
wi7i•
7
iiiiiw•
7
α
β β

To

SvailtP3– ehmikMv eyphpccpyvtympathmeiptcvt0eymvbrpMpctivPik0nvtM phpccpy)n Mbeiettem
Sympatphepicvp0p–6a+pmy3p6tphepMavp00pbcarbcn
Sympathmheyicvh0pat–ata6v+hp3vmaiiv+yiiv6M0p3a6h6vh0vehbheh0rvnympathy Sympath
Sh0e6vpovy0evh03hnhp6vp3ava0lM(avp3ypvmto66Vih0)6vp3av4a4pheavm3yh0vo–vp3av0a+iMv–ot(aevPnkhieh0rv
niom)6dvpovp3av4a4pheoriMmy0vmaiiv+yiivnym)no0a vv
eiS
sty(V0aryphbavnympathyvy6v+aiivy6v6pta4pomommyiFvro0omommyiFv(a0h0romommyivh0–ampho06Fvy0p3ty2Fv
eh4p3p3athyFvry6vry0rta0a v
cvptpy0v–6h+
uM4at6a06hphbhpMvtaympho06v1ty63a6FvktphmythyFvy0rhoaea(yFv–abatFvytp3tyirhyFvy0y43Miy2h6Rcvs• v
eh6pktny0ma6cvtytaiMvmoihph6 v
S3M+bh+–+r+ymh
shba0vh ( votvh b votvnMv6io+vh b vh0–k6ho0 v-y66a6vh0povyiivnoeMv€khe6cva2mtapaevh0vp3avkth0av1niom)aevnMv
4tona0amheR v‚(4hmhiih0vh6vrhba0vh b v
Snh ophmbn lvp(
V+hphm0ty+ƒopva„amphbavyryh06pv6py43Miomommhv1ekavpovSViympy(y6aRvy0evpov6pta4pomommhv+3hm3v3ybavh(4yhtaev
SViympy(vnh0eh0rvekavpov(kpypho0vo–vp3avpty064a4phey6ava0lM(a 
)4+yp0v–4aptmh•0ymphbypaevnMvnympathyivSViympy(y6a6cvk6kyiiMvrhba0v+hp3vmiybkiy0hmvymhev+3hm3vh03hnhp6v SViympy(y6a6 v



M








 
 
M 
­€
­€
€

‚
ƒ„

­  …
‚‚  









 


­€‚


ƒ


Excretion valutengseiDhxiolvg
eocgtedBeasuot
utnBr
Excd
Excretion via lungs
Excretiecion ovtirtar rlnugrviroxcrstlDrvhrnclueclrcvoxcnrsDrvohrdco stBvhdrtnrsDrvohrcyencovtiruiex igcl
Drug in exhaled air
B
i
l
ia
r
y
 e
xcrExcre
tion vExalrucxE EgsiExcre lD hcdeED
BesyaenEd dion EgsiExcr
e
 l
D
 h
c
d
e
E
D
BesyaenEd dion ri
vExalrucxE ce oiceE
tion ri vExalrucxE
ce aEsE
tion vExalrucxE
ce lrdD
cucaiD EgsiExcre
tion ce lrdD
ya E 
ya E 
Dx
Edosxcre
•DdiruD c
Excr
etion va
Excr
etleuegsva
•gcdaxcre
re•onaxcre



R&D 7e Ch 35 , pp34p;pH D&2 Ch 75 , ;1
R&D 7eCh7h35Ch h,7p4 &7 ;h7HCp4h27hp ;hC7p47e47H45;e41h,7-&C7&C7eD7e7h e&p h7
6Chh7Ch3e7C&9hDDhD7eCh7p3&h,
R&D 7eC&he
3&5eh5,Dp
R&D  7eCh37&5 ,ph ,47DC,7;5Cp,e7DpC5447H2,73 5&,Ch DC7&,&1CD-,717H2,7C,44hC,7-7H2,7C,-D 
↓↓↓↓↓ ↓↓↓↑↓
↓↑↓
4C;C&he
H72e75,Dp
↑↓↓↓↓↑↓
↓↓↓↓↓↓↓
•↑↑↓•••↑↓
↓↓↓↓↓•↑↓
↓•↓
4C;C&he
e7h;HDe15,Dp
 ↓↓↑↓↓↓
-↓↓€↓↓↑↑↓↓
↓↓↓‚&C9h,7eep3h7,p;ChDpD7;H,793D;97967Dpep
eCh237,273D p D;,737pC,D3,e7397C,ehp27C,D39C;97De7pC,D327p ,DCDp,7•ƒD7,7h3,6h 
7eCh279,Ce93,•










???




?

?

?????
€
?

?

???????




…




???????

?

TyrosrinireNADOronPpNPPNyn Py,euva2.a?
TyrosineNroniArDoOoDiPparomeMaivromsovmNOtNrvrNnicoMNOvDPiDDimv
Tyrosine
Ty
Noradrenergic
varicosity
Ty
NA
α
r
Ty
β
r
α
o
β
o
DOPA
Dopamine
Dopa decarboxylase
Dopamine
Movement
Acts on, causes, 
gives rise to
s
s
s
s
s
Tyrosine
Tyrosine
Salbutamol,
terbutaline,
salmeterol
s
s
Atenolol, metoprolol, propranolol, oxprenolol
i
Propranolol, oxprenolol
Noradoenrad gicndaivrads
i
Uptake 1
s
s

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&.g hn dhGw toAsc‚
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis

R&D 7e7C&h24&CD,Cp3
R&D 7e7C&h24&CD,Cp3
0&D ,e;C&h
H5;H;8pH &C&
0&D ,e;C&h
H5;H;8pH &C&
-5,9,e;3
-5,9,e;3
H5;4&C
)bpmwmti 0;5H 7C&h2e7,9;5H 7C&h
yklgitmgldstioa,m isti
vit.mgea,mgniw
fdbpbck.
BGI
)Tr
fs..kia bcbui
)m,s,ilnsxiazamgaGaB
lbstab•igitn
vlstmndbpbcs,angb,n
tikgmt
(tnigtikgmtast
 mg.bpadmgt
rmgldstioa sbcmgldstio
yklgitmgldstioa,m isti
Bindisi toaht
•m,k.a,igkpik.

ReaoftFrtiidea pitf (.r etpr.Fdahon Fdoe )Aoloudr frpcg e.raroFa-uoetmy(t dtu bFtio
Reductuioun furupa hude.uatuiounafuru(F
Reduction of neuropathic pain. (For antidepressant action see set 24).Reducti
Analgesic action of antidepressants is mainly due to inhibition of the opening of neuronal 
voltage-gated Na

channels (Na
v
 1.7 subtype) rather than to inhibition of monoamine reuptake. Na
+
 
channel block reduces pain transmission from site of nerve injury. 
onR
Postherpetic neuralgia, diabetic peripheral neuropathy, neuropathic cancer pain. futuerfpaih
Sedation (antihistamine action, less with nortriptyline). Blurred vision, dry mouth, constipation,
urinary retention (antimuscarinic action). Postural hypotension (R
1
-adrenoceptor antagonism).
Overdose potentially fatal due to cardiac dysrhythmia, severe hypotension, seizure and CNS
depression. Increased risk of suicide in young patients. 
R.(hFihphshedi
Oral administration. Hepatic P450 metabolism (nortriptyline is a metabolite of amitriptyline).
T
0.5
 12–24h.
R2i4)uidF24Aful

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&Goboh,nfdnAscƒ
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
prexrfn,TtmmtInb,fuNcrmbdn,rS
srSNr,hn,A
,bether,reAnN
n,cnGnInb,
srSNr,hn,A
SrebIb,reAnNu
r,drRctgn,reAnN
n,cnGnInb,
prvebRtIcnNfRtn,
CgvItmtIru
SvGSIt,Nrfl
lebSItAgt,hn,S
•,R,
r,drRctgn,
fRn,tgfNbeh
R&DCh
lrenRcrei

Pethidine, fentanyl
Pethidine, fentanyl
Methadone,
propoxyphene
Methadone,
propoxyphene
Tramadol
Tramadol
Ibuprofen
Naloxone Morphine, diamorphine,
buprenorphine, codeine
Sensory cortex
Thalamus
PAG
NRM
Tissue damage
Nociceptive C or A B
pain aferent
Spinothalamic tract
neuron
Interneuron in
dorsal horn
Morphine, diamorphine,
buprenorphine, codeine
Amitriptyline
Carbamazepine
Locus ceruleus

G-protrerinNCiN5pt n5b5ordtgdwastbim5lrpr5ei1G-prot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
7
ibn5oopdei -CsiToeTlp

????
??
???
inG
? ??
?? ?
???????? ?
? ?? ????
NCrtr-5CHTe 
? ????
??

Gbd ge H w -pe
???
?? ??
??????
?
?
GaesmrepgaslCr1
? ?
?
7
? ?
?
7
?
7
?
7
?
7
α
β β

To

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o

G-protrerinNCiN5pt 35b5ordtgdwastoil-4wm5lrpr5ei6td-m5lrpr5ei1HT -btot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
b
ibn5oopdei -CsiToeTlp
ffmm)uffmm)f/RfT)fx
T/mu••(u•••m/TxP
tnpidC3p-iN•iTob-p5epeiTCoTe5tTCoiC itnpi3p5ad i25eTbidCb5d
5o5petnptTbi••-•g
inG
€ ‚
ƒ   
NCrtr-5CHTe 
­ „ƒ …­
-CNTr5b5Topidpeeib5-lTCtC…Tbg•
Gbd ge H w -pe
†  ‡ˆ‰ 
   † 
­†
‰gˆ
iŠ‹Œng
GaesmrepgaslCr1
Ž ‘

7
Ž 
wi7i•
7
iiiiiw•
7
wi7i•
7
iiiiiw•
7
α
β β

To

FPouGuGplmuGmyh9LŽ‘iLaglatGgmhlh9Luagga•mgGmyhtyPLaOloySLHLySrn
R&D 7e Ch 29, p 367; D&H 2e Ch 27, p 67
FSHLySpoLthaSMA, monaieDdemopnAiApn,em,pnDoenaeoDpeAapmNrna Al5e-nH elDaAaeTaAledDheomTaAmemoleyDinpnoHeDd
, AiDp AhmxteOAax5e,naxrmpnos5ecAoAhmrrteTaAlenoe,DiNnompnDoeunp eDp AhemopnAiApn,a5e
lLaaLmuahustf,pnDoeynmeb/
g
ehA,AxpDha5evaAledDheomTaAmemoleyDinpnoHemaaD,nmpAleunp e,mo,Ahe, AiDp Ahmxt5e
ShDomNnoDrenaep Aeimnoem,pnyAenoHhAlnAopeOpAphm tlhD,moomNnoDrseDde,moomNnaReomNnrDoAenaemeatop Apn,
momrDHTA5eMmte,mTaAelAxAolAo,A5ewmNnrDoAenaeem,pnyAeNteiDTp Ref
 5-
e€ 5
PSerhiuaua
rS SOphr
LapLghautpt
‚5H5emxhAxnpmopeNrD,ƒaeaTNapmo,Ae„ehA,AxpDhaenoep AeyDinpnoHe,AophA5efl…To,pedDhephAmpiAopeDd
, AiDp Ahmxt†nolT,AleemolexDap†DxAhmpnyAeomTaAmemoleyDinpnoH5e‡hmrrtem,pnyA5
MApmNDrnaAleNte,tpD, hDiAe„ˆ- eatapAienoernyAh5ef
 5-
eg€ 5

Diagrm of ’•h• gi aP shrgDiap•
Diaggrm a omfthieahimf
nfsg at cdupicdymPp, 
nfsg at cde githaPtit
 cps cdupicd dtmPictdymPp, 
D sg at cde githaPtitdthatit
agat,eahr hisd d fh gisdf gymptdtth ,
igpt td dash giadasph 
miftd •••dormP gadhmif
•Ppicdt sg himf
•aPatmgehimf
Dgp•dtic d • shtd
 •••dmeimict•dafhisrmPif g•ist
 fc gPif•dcit at •dafi h
-fhiash giaPt
€t,mhisdPmac

“ogfƒ‹bmvof,ffgbhoggfE••D.oD.E
fbu


fb
ufpfkoL
D.LLkLgL







  
­ €‚
ƒ „

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&.g hn dhGw toAsc‚
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis

R&D 7e7C&h24&CD,Cp3
R&D 7e7C&h24&CD,Cp3
0&D ,e;C&h
H5;H;8pH &C&
0&D ,e;C&h
H5;H;8pH &C&
-5,9,e;3
-5,9,e;3
H5;4&C
)bpmwmti 0;5H 7C&h2e7,9;5H 7C&h
yklgitmgldstioa,m isti
vit.mgea,mgniw
fdbpbck.
BGI
)Tr
fs..kia bcbui
)m,s,ilnsxiazamgaGaB
lbstab•igitn
vlstmndbpbcs,angb,n
tikgmt
(tnigtikgmtast
 mg.bpadmgt
rmgldstioa sbcmgldstio
yklgitmgldstioa,m isti
Bindisi toaht
•m,k.a,igkpik.

ReaoftFrtiidea pitf (.r etpr.Fdahon Fdoe )Aoloudr frpcg e.raroFa-uoetmy(t dtu bFtio
Reductuioun furupa hude.uatuiounafuru(F
Reduction of neuropathic pain. (For antidepressant action see set 24).Reducti
Analgesic action of antidepressants is mainly due to inhibition of the opening of neuronal 
voltage-gated Na

channels (Na
v
 1.7 subtype) rather than to inhibition of monoamine reuptake. Na
+
 
channel block reduces pain transmission from site of nerve injury. 
onR
Postherpetic neuralgia, diabetic peripheral neuropathy, neuropathic cancer pain. futuerfpaih
Sedation (antihistamine action, less with nortriptyline). Blurred vision, dry mouth, constipation,
urinary retention (antimuscarinic action). Postural hypotension (R
1
-adrenoceptor antagonism).
Overdose potentially fatal due to cardiac dysrhythmia, severe hypotension, seizure and CNS
depression. Increased risk of suicide in young patients. 
R.(hFihphshedi
Oral administration. Hepatic P450 metabolism (nortriptyline is a metabolite of amitriptyline).
T
0.5
 12–24h.
R2i4)uidF24Aful

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&Goboh,nfdnAscƒ
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
prexrfn,TtmmtInb,fuNcrmbdn,rS
srSNr,hn,A
,bether,reAnN
n,cnGnInb,
srSNr,hn,A
SrebIb,reAnNu
r,drRctgn,reAnN
n,cnGnInb,
prvebRtIcnNfRtn,
CgvItmtIru
SvGSIt,Nrfl
lebSItAgt,hn,S
•,R,
r,drRctgn,
fRn,tgfNbeh
R&DCh
lrenRcrei

Pethidine, fentanyl
Pethidine, fentanyl
Methadone,
propoxyphene
Methadone,
propoxyphene
Tramadol
Tramadol
Ibuprofen
Naloxone Morphine, diamorphine,
buprenorphine, codeine
Sensory cortex
Thalamus
PAG
NRM
Tissue damage
Nociceptive C or A B
pain aferent
Spinothalamic tract
neuron
Interneuron in
dorsal horn
Morphine, diamorphine,
buprenorphine, codeine
Amitriptyline
Carbamazepine
Locus ceruleus

?







   
?
­   
€ ‚ƒ„

+–disdplpdace NdilA2cAAc–l2.

Smoth us
βα
Smotho u oscl
 idce–NcA2
βα
cl
β

βα
 NAe




Smoth ushmcltetsh
NA2 is1Ai sdp
+
+
+
+
1piAl 
1piAl 
Smoth musoc
pe isp–dNAec
2–dlepe ad
+
+
1peAadadc


1lep–lNAec displace NA
Smoth u



+

+
dc s
+
+
p–l2sda2NA

β
2
α
1
β
1
Smooth muscle cell S SS
↑β



+




Smoth uscl

Ž

Surrfactn wa ifafh emlmcSurfacuSursy
Surfactnf wihreerefmrlrwatntnsfygiimfsgohierfhinhrnlwcltine
Glycogenolysis in
muscle and liver
Absorption of
glucose from GIT
Gluconeogenesis
in liver
Uptake and utilisation
of glucose by tissues
Glycogen synthesis in
muscle and liver
Blood glucose

G-protrerinNCiN5pt n5b5ordtgdwastbim5lrpr5ei1G-prot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
7
ibn5oopdei -CsiToeTlp

????
??
???
inG
? ??
?? ?
???????? ?
? ?? ????
NCrtr-5CHTe 
? ????
??

Gbd ge H w -pe
???
?? ??
??????
?
?
GaesmrepgaslCr1
? ?
?
7
? ?
?
7
?
7
?
7
?
7
α
β β

To

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o

G-protrerinNCiN5pt 35b5ordtgdwastoil-4wm5lrpr5ei6td-m5lrpr5ei1HT -btot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
b
ibn5oopdei -CsiToeTlp
ffmm)uffmm)f/RfT)fx
T/mu••(u•••m/TxP
tnpidC3p-iN•iTob-p5epeiTCoTe5tTCoiC itnpi3p5ad i25eTbidCb5d
5o5petnptTbi••-•g
inG
€ ‚
ƒ   
NCrtr-5CHTe 
­ „ƒ …­
-CNTr5b5Topidpeeib5-lTCtC…Tbg•
Gbd ge H w -pe
†  ‡ˆ‰ 
   † 
­†
‰gˆ
iŠ‹Œng
GaesmrepgaslCr1
Ž ‘

7
Ž 
wi7i•
7
iiiiiw•
7
wi7i•
7
iiiiiw•
7
α
β β

To



























DbDfDfE
//fDfDfS
g•

mfE
ff•••fS
g•
mfE
mD•/fE
DbDfDfE
Db/f•S
••

• 
-
Db/f•S
DbDfDfE
DmD
/fS
•€
-
••
-
•D
m
g

mfEb•DE
ff•••fS








 ­€‚
ƒ

„…‚ †‡ 
­

ˆ‰

? aP2 cihL
IL-2Pl2as2m c2ee2mPAnmPPt2-Li2gl2as2gpc2e2Ar
IL-2Pl-asmL  cseLAn a-sn tn-tliPlg tpsrtni-Pa-asiPl-sPtcsT in-s Ts=-Pilsn tliPnlg tpIL-2Pla
,LAnPe tsPnlg2Pl-asPc-thLPl-snhnLPa-smhsPnlgtes ts,B1i l-gtsn A1L-csi-n-1l iasLgt-csl s,
a
psrla
Pnlg tasl=Aasggnsl= a-s TsPci-tPLgt-sPnlg2PlgtesIBPci-t n-1l iapsrls-L-2Pl-asmL  cseLAn a-smh
algALPlgtes=-1PlgnseLAn t- e-t-agasPtcseLhn e-t LhagasPtcsmhsgt=gmglgteseLhn e-tsahtl=-agap
smI
I-ie-tnhsli-Pl-tls Ts=h1 eLhnP-gns--ie-tnhsnPAa-csmhsgtaALgts 2-ic a-s=-ts iPLs isgp2p
eLAn a-sPcgtgaliPlg tsgast ls1 aagmL-ps•La sAa-csl sli-Pls=-PilssTPgLAi-s1i-ng1glPl-csmhs
IBPci-t n-1l isPtlPe tgalap
 c2l2LecAnat
,LAnPe tsgasPs1-1lgc-s= i t-s=gn=sAalsm-seg2-tsmhsgt•-nlg tps•LPaPs=PLTBLgT-s•gtpIiagp2a-rigTc2=
??IBmL n-ias isgl=s1=P- n=i  nhl PpI,htrat
tBtL-a

Thee diagrmdrs d orwc-ciy oosfnThe?
The diahgremdsowhece-emds
tdcgwheiemdsoigndwheiemdThe diag fiu,hei
The diag
Fagt lud
fiu,hei
pdnbltrei vluewheng-lidsocelwheng-lid
ThOalwdilhOueuoei
r,uahdogimohexdt
F ultcneliolb
wh,aludobtlroTfy
Th,aludoeioeinduneid
Th,alidlwdidueu
eiohexdt
bmynWahncwh.yruronyrpc
lbowh,aludo Ooneuu,du
Suvtpeachovcy-aorohrc
r,uahdogimohexdt
•hllmowh,alud
•lrchd•
tnsfp-vwsnyaohrchdppw
vluewheng-lidsocelwheng-lid
fiu,heiotdhdgudobtlr
•oadhhuoeiocgiatdguo
Surfactnf wihreerefmrlrwatntnsfygiimfsgohierfhinhrnlwcltine

?



























DbDfDfE
//fDfDfS
g•

mfE
ff•••fS
g•
mfE
mD•/fE
DbDfDfE
Db/f•S
••

• 
-
Db/f•S
DbDfDfE
DmD
/fS
•€
-
••
-
•D
m
g

mfEb•DE
ff•••fS








 ­€‚
ƒ

„…‚ †‡ 
­

ˆ‰

SvailtP3– ehmikMv eyphpccpyvtympathmeiptcvt0eymvbrpMpctivPik0nvtM phpccpy)n Mbeiettem
Sympatphepicvp0p–6a+pmy3p6tphepMavp00pbcarbcn
Sympathmheyicvh0pat–ata6v+hp3vmaiiv+yiiv6M0p3a6h6vh0vehbheh0rvnympathy Sympath
Sh0e6vpovy0evh03hnhp6vp3ava0lM(avp3ypvmto66Vih0)6vp3av4a4pheavm3yh0vo–vp3av0a+iMv–ot(aevPnkhieh0rv
niom)6dvpovp3av4a4pheoriMmy0vmaiiv+yiivnym)no0a vv
eiS
sty(V0aryphbavnympathyvy6v+aiivy6v6pta4pomommyiFvro0omommyiFv(a0h0romommyivh0–ampho06Fvy0p3ty2Fv
eh4p3p3athyFvry6vry0rta0a v
cvptpy0v–6h+
uM4at6a06hphbhpMvtaympho06v1ty63a6FvktphmythyFvy0rhoaea(yFv–abatFvytp3tyirhyFvy0y43Miy2h6Rcvs• v
eh6pktny0ma6cvtytaiMvmoihph6 v
S3M+bh+–+r+ymh
shba0vh ( votvh b votvnMv6io+vh b vh0–k6ho0 v-y66a6vh0povyiivnoeMv€khe6cva2mtapaevh0vp3avkth0av1niom)aevnMv
4tona0amheR v‚(4hmhiih0vh6vrhba0vh b v
Snh ophmbn lvp(
V+hphm0ty+ƒopva„amphbavyryh06pv6py43Miomommhv1ekavpovSViympy(y6aRvy0evpov6pta4pomommhv+3hm3v3ybavh(4yhtaev
SViympy(vnh0eh0rvekavpov(kpypho0vo–vp3avpty064a4phey6ava0lM(a 
)4+yp0v–4aptmh•0ymphbypaevnMvnympathyivSViympy(y6a6cvk6kyiiMvrhba0v+hp3vmiybkiy0hmvymhev+3hm3vh03hnhp6v SViympy(y6a6 v



M








 
 
M 
­€
­€
€

‚
ƒ„

­  …
‚‚  









 


­€‚


ƒ


? aP2 cihL
IL-2Pl2as2m c2ee2mPAnmPPt2-Li2gl2as2gpc2e2Ar
IL-2Pl-asmL  cseLAn a-sn tn-tliPlg tpsrtni-Pa-asiPl-sPtcsT in-s Ts=-Pilsn tliPnlg tpIL-2Pla
,LAnPe tsPnlg2Pl-asPc-thLPl-snhnLPa-smhsPnlgtes ts,B1i l-gtsn A1L-csi-n-1l iasLgt-csl s,
a
psrla
Pnlg tasl=Aasggnsl= a-s TsPci-tPLgt-sPnlg2PlgtesIBPci-t n-1l iapsrls-L-2Pl-asmL  cseLAn a-smh
algALPlgtes=-1PlgnseLAn t- e-t-agasPtcseLhn e-t LhagasPtcsmhsgt=gmglgteseLhn e-tsahtl=-agap
smI
I-ie-tnhsli-Pl-tls Ts=h1 eLhnP-gns--ie-tnhsnPAa-csmhsgtaALgts 2-ic a-s=-ts iPLs isgp2p
eLAn a-sPcgtgaliPlg tsgast ls1 aagmL-ps•La sAa-csl sli-Pls=-PilssTPgLAi-s1i-ng1glPl-csmhs
IBPci-t n-1l isPtlPe tgalap
 c2l2LecAnat
,LAnPe tsgasPs1-1lgc-s= i t-s=gn=sAalsm-seg2-tsmhsgt•-nlg tps•LPaPs=PLTBLgT-s•gtpIiagp2a-rigTc2=
??IBmL n-ias isgl=s1=P- n=i  nhl PpI,htrat
tBtL-a

Thee diagrmdrs d orwc-ciy oosfnThe?
The diahgremdsowhece-emds
tdcgwheiemdsoigndwheiemdThe diag fiu,hei
The diag
Fagt lud
fiu,hei
pdnbltrei vluewheng-lidsocelwheng-lid
ThOalwdilhOueuoei
r,uahdogimohexdt
F ultcneliolb
wh,aludobtlroTfy
Th,aludoeioeinduneid
Th,alidlwdidueu
eiohexdt
bmynWahncwh.yruronyrpc
lbowh,aludo Ooneuu,du
Suvtpeachovcy-aorohrc
r,uahdogimohexdt
•hllmowh,alud
•lrchd•
tnsfp-vwsnyaohrchdppw
vluewheng-lidsocelwheng-lid
fiu,heiotdhdgudobtlr
•oadhhuoeiocgiatdguo
Surfactnf wihreerefmrlrwatntnsfygiimfsgohierfhinhrnlwcltine

?

SvailtP3– ehmikMv eyphpccpyvtympathmeiptcvt0eymvbrpMpctivPik0nvtM phpccpy)n Mbeiettem
Sympatphepicvp0p–6a+pmy3p6tphepMavp00pbcarbcn
Sympathmheyicvh0pat–ata6v+hp3vmaiiv+yiiv6M0p3a6h6vh0vehbheh0rvnympathy Sympath
Sh0e6vpovy0evh03hnhp6vp3ava0lM(avp3ypvmto66Vih0)6vp3av4a4pheavm3yh0vo–vp3av0a+iMv–ot(aevPnkhieh0rv
niom)6dvpovp3av4a4pheoriMmy0vmaiiv+yiivnym)no0a vv
eiS
sty(V0aryphbavnympathyvy6v+aiivy6v6pta4pomommyiFvro0omommyiFv(a0h0romommyivh0–ampho06Fvy0p3ty2Fv
eh4p3p3athyFvry6vry0rta0a v
cvptpy0v–6h+
uM4at6a06hphbhpMvtaympho06v1ty63a6FvktphmythyFvy0rhoaea(yFv–abatFvytp3tyirhyFvy0y43Miy2h6Rcvs• v
eh6pktny0ma6cvtytaiMvmoihph6 v
S3M+bh+–+r+ymh
shba0vh ( votvh b votvnMv6io+vh b vh0–k6ho0 v-y66a6vh0povyiivnoeMv€khe6cva2mtapaevh0vp3avkth0av1niom)aevnMv
4tona0amheR v‚(4hmhiih0vh6vrhba0vh b v
Snh ophmbn lvp(
V+hphm0ty+ƒopva„amphbavyryh06pv6py43Miomommhv1ekavpovSViympy(y6aRvy0evpov6pta4pomommhv+3hm3v3ybavh(4yhtaev
SViympy(vnh0eh0rvekavpov(kpypho0vo–vp3avpty064a4phey6ava0lM(a 
)4+yp0v–4aptmh•0ymphbypaevnMvnympathyivSViympy(y6a6cvk6kyiiMvrhba0v+hp3vmiybkiy0hmvymhev+3hm3vh03hnhp6v SViympy(y6a6 v



M








 
 
M 
­€
­€
€

‚
ƒ„

­  …
‚‚  









 


­€‚


ƒ


????????
R&D 7e Ch 24, p 304- D&5 ;e Ch 2H, p 08
R&D 7eC
h2R
R4C,p CD3 4,0- 5
;- e &H-89C
D.LLkLgL
R&D 7eCh &24& e&,



;C3537D4C2

 ­

€‚ƒƒ
ƒƒƒƒ
?
???
??
??????
??
???


‚






















?












? ?




??




SvailtP3– ehmikMv eyphpccpyvtympathmeiptcvt0eymvbrpMpctivPik0nvtM phpccpy)n Mbeiettem
Sympatphepicvp0p–6a+pmy3p6tphepMavp00pbcarbcn
Sympathmheyicvh0pat–ata6v+hp3vmaiiv+yiiv6M0p3a6h6vh0vehbheh0rvnympathy Sympath
Sh0e6vpovy0evh03hnhp6vp3ava0lM(avp3ypvmto66Vih0)6vp3av4a4pheavm3yh0vo–vp3av0a+iMv–ot(aevPnkhieh0rv
niom)6dvpovp3av4a4pheoriMmy0vmaiiv+yiivnym)no0a vv
eiS
sty(V0aryphbavnympathyvy6v+aiivy6v6pta4pomommyiFvro0omommyiFv(a0h0romommyivh0–ampho06Fvy0p3ty2Fv
eh4p3p3athyFvry6vry0rta0a v
cvptpy0v–6h+
uM4at6a06hphbhpMvtaympho06v1ty63a6FvktphmythyFvy0rhoaea(yFv–abatFvytp3tyirhyFvy0y43Miy2h6Rcvs• v
eh6pktny0ma6cvtytaiMvmoihph6 v
S3M+bh+–+r+ymh
shba0vh ( votvh b votvnMv6io+vh b vh0–k6ho0 v-y66a6vh0povyiivnoeMv€khe6cva2mtapaevh0vp3avkth0av1niom)aevnMv
4tona0amheR v‚(4hmhiih0vh6vrhba0vh b v
Snh ophmbn lvp(
V+hphm0ty+ƒopva„amphbavyryh06pv6py43Miomommhv1ekavpovSViympy(y6aRvy0evpov6pta4pomommhv+3hm3v3ybavh(4yhtaev
SViympy(vnh0eh0rvekavpov(kpypho0vo–vp3avpty064a4phey6ava0lM(a 
)4+yp0v–4aptmh•0ymphbypaevnMvnympathyivSViympy(y6a6cvk6kyiiMvrhba0v+hp3vmiybkiy0hmvymhev+3hm3vh03hnhp6v SViympy(y6a6 v

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&.g hn dhGw toAsc‚
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis

R&D 7e7C&h24&CD,Cp3
R&D 7e7C&h24&CD,Cp3
0&D ,e;C&h
H5;H;8pH &C&
0&D ,e;C&h
H5;H;8pH &C&
-5,9,e;3
-5,9,e;3
H5;4&C
)bpmwmti 0;5H 7C&h2e7,9;5H 7C&h
yklgitmgldstioa,m isti
vit.mgea,mgniw
fdbpbck.
BGI
)Tr
fs..kia bcbui
)m,s,ilnsxiazamgaGaB
lbstab•igitn
vlstmndbpbcs,angb,n
tikgmt
(tnigtikgmtast
 mg.bpadmgt
rmgldstioa sbcmgldstio
yklgitmgldstioa,m isti
Bindisi toaht
•m,k.a,igkpik.

ReaoftFrtiidea pitf (.r etpr.Fdahon Fdoe )Aoloudr frpcg e.raroFa-uoetmy(t dtu bFtio
Reductuioun furupa hude.uatuiounafuru(F
Reduction of neuropathic pain. (For antidepressant action see set 24).Reducti
Analgesic action of antidepressants is mainly due to inhibition of the opening of neuronal 
voltage-gated Na

channels (Na
v
 1.7 subtype) rather than to inhibition of monoamine reuptake. Na
+
 
channel block reduces pain transmission from site of nerve injury. 
onR
Postherpetic neuralgia, diabetic peripheral neuropathy, neuropathic cancer pain. futuerfpaih
Sedation (antihistamine action, less with nortriptyline). Blurred vision, dry mouth, constipation,
urinary retention (antimuscarinic action). Postural hypotension (R
1
-adrenoceptor antagonism).
Overdose potentially fatal due to cardiac dysrhythmia, severe hypotension, seizure and CNS
depression. Increased risk of suicide in young patients. 
R.(hFihphshedi
Oral administration. Hepatic P450 metabolism (nortriptyline is a metabolite of amitriptyline).
T
0.5
 12–24h.
R2i4)uidF24Aful

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&Goboh,nfdnAscƒ
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
prexrfn,TtmmtInb,fuNcrmbdn,rS
srSNr,hn,A
,bether,reAnN
n,cnGnInb,
srSNr,hn,A
SrebIb,reAnNu
r,drRctgn,reAnN
n,cnGnInb,
prvebRtIcnNfRtn,
CgvItmtIru
SvGSIt,Nrfl
lebSItAgt,hn,S
•,R,
r,drRctgn,
fRn,tgfNbeh
R&DCh
lrenRcrei

Pethidine, fentanyl
Pethidine, fentanyl
Methadone,
propoxyphene
Methadone,
propoxyphene
Tramadol
Tramadol
Ibuprofen
Naloxone Morphine, diamorphine,
buprenorphine, codeine
Sensory cortex
Thalamus
PAG
NRM
Tissue damage
Nociceptive C or A B
pain aferent
Spinothalamic tract
neuron
Interneuron in
dorsal horn
Morphine, diamorphine,
buprenorphine, codeine
Amitriptyline
Carbamazepine
Locus ceruleus

G-protrerinNCiN5pt n5b5ordtgdwastbim5lrpr5ei1G-prot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
7
ibn5oopdei -CsiToeTlp

????
??
???
inG
? ??
?? ?
???????? ?
? ?? ????
NCrtr-5CHTe 
? ????
??

Gbd ge H w -pe
???
?? ??
??????
?
?
GaesmrepgaslCr1
? ?
?
7
? ?
?
7
?
7
?
7
?
7
α
β β

To

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o

G-protrerinNCiN5pt 35b5ordtgdwastoil-4wm5lrpr5ei6td-m5lrpr5ei1HT -btot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
b
ibn5oopdei -CsiToeTlp
ffmm)uffmm)f/RfT)fx
T/mu••(u•••m/TxP
tnpidC3p-iN•iTob-p5epeiTCoTe5tTCoiC itnpi3p5ad i25eTbidCb5d
5o5petnptTbi••-•g
inG
€ ‚
ƒ   
NCrtr-5CHTe 
­ „ƒ …­
-CNTr5b5Topidpeeib5-lTCtC…Tbg•
Gbd ge H w -pe
†  ‡ˆ‰ 
   † 
­†
‰gˆ
iŠ‹Œng
GaesmrepgaslCr1
Ž ‘

7
Ž 
wi7i•
7
iiiiiw•
7
wi7i•
7
iiiiiw•
7
α
β β

To

Fre ff atyrc ric ratdtre ff aysCcisELpcT ratLyEac LVrapm2HHe D73heHR&HH
Fre fatye cridc sre fCEL pesEoiLnl VEsrdED nC sre VyiTtlsniC iG tynl ElnT
R&D 7Fre faetyetcaeyiadsdy fCtFyEeyLefdFCepCF 
oap FEnetyepdtcdFtFre faetye asyrFtFyEeyLefdpta
CdlrtporeFEetcaeVyFEtrDeTcpnyCltareaEnfoLetca
CdlrtporepE edaoapraeFEGp>>ptydle>a FptydrDe
ehmTHbvA(hwA)
bvA(hwA)
>ynl ElnT
bpEtcFEaeyuF pra
bpEtcFEaeyuF pra

FPouGuGplmuGmyh9LŽ‘iLaglatGgmhlh9Luagga•mgGmyhtyPLaOloySLHLySrn
R&D 7e Ch 29, p 367; D&H 2e Ch 27, p 67
FSHLySpoLthaSMA, monaieDdemopnAiApn,em,pnDoenaeoDpeAapmNrna Al5e-nH elDaAaeTaAledDheomTaAmemoleyDinpnoHeDd
, AiDp AhmxteOAax5e,naxrmpnos5ecAoAhmrrteTaAlenoe,DiNnompnDoeunp eDp AhemopnAiApn,a5e
lLaaLmuahustf,pnDoeynmeb/
g
ehA,AxpDha5evaAledDheomTaAmemoleyDinpnoHemaaD,nmpAleunp e,mo,Ahe, AiDp Ahmxt5e
ShDomNnoDrenaep Aeimnoem,pnyAenoHhAlnAopeOpAphm tlhD,moomNnoDrseDde,moomNnaReomNnrDoAenaemeatop Apn,
momrDHTA5eMmte,mTaAelAxAolAo,A5ewmNnrDoAenaeem,pnyAeNteiDTp Ref
 5-
e€ 5
PSerhiuaua
rS SOphr
LapLghautpt
‚5H5emxhAxnpmopeNrD,ƒaeaTNapmo,Ae„ehA,AxpDhaenoep AeyDinpnoHe,AophA5efl…To,pedDhephAmpiAopeDd
, AiDp Ahmxt†nolT,AleemolexDap†DxAhmpnyAeomTaAmemoleyDinpnoH5e‡hmrrtem,pnyA5
MApmNDrnaAleNte,tpD, hDiAe„ˆ- eatapAienoernyAh5ef
 5-
eg€ 5

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&.g hn dhGw toAsc‚
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis

R&D 7e7C&h24&CD,Cp3
R&D 7e7C&h24&CD,Cp3
0&D ,e;C&h
H5;H;8pH &C&
0&D ,e;C&h
H5;H;8pH &C&
-5,9,e;3
-5,9,e;3
H5;4&C
)bpmwmti 0;5H 7C&h2e7,9;5H 7C&h
yklgitmgldstioa,m isti
vit.mgea,mgniw
fdbpbck.
BGI
)Tr
fs..kia bcbui
)m,s,ilnsxiazamgaGaB
lbstab•igitn
vlstmndbpbcs,angb,n
tikgmt
(tnigtikgmtast
 mg.bpadmgt
rmgldstioa sbcmgldstio
yklgitmgldstioa,m isti
Bindisi toaht
•m,k.a,igkpik.



























DbDfDfE
//fDfDfS
g•

mfE
ff•••fS
g•
mfE
mD•/fE
DbDfDfE
Db/f•S
••

• 
-
Db/f•S
DbDfDfE
DmD
/fS
•€
-
••
-
•D
m
g

mfEb•DE
ff•••fS








Excretion valutengseiDhxiolvg
eocgtedBeasuot
utnBr
Excd
Excretion via lungs
Excretiecion ovtirtar rlnugrviroxcrstlDrvhrnclueclrcvoxcnrsDrvohrdco stBvhdrtnrsDrvohrcyencovtiruiex igcl
Drug in exhaled air
B
i
l
ia
r
y
 e
xcrExcre
tion vExalrucxE EgsiExcre lD hcdeED
BesyaenEd dion EgsiExcr
e
 l
D
 h
c
d
e
E
D
BesyaenEd dion ri
vExalrucxE ce oiceE
tion ri vExalrucxE
ce aEsE
tion vExalrucxE
ce lrdD
cucaiD EgsiExcre
tion ce lrdD
ya E 
ya E 
Dx
Edosxcre
•DdiruD c
Excr
etion va
Excr
etleuegsva
•gcdaxcre
re•onaxcre

5r.my3.avry 2tA3r1eUENh.eAth
Fungalg igfecgttgeoaseok,gnuhgolg igfocgtgaa
1. AtacAhmAenmtn2aEnrmyAntyhdmNahmwah.c. hAtvcA.tmacAv. d1. Atac
i.Amy rnthA..romsa3macAmUatA23m. m1gartn .cnUA.th4mUatA23m. mTgNfmtncnUA.thdhm1
f.mAtnaAmU.hAgUatAysmeans.ttealndenAaA.2nErcy
DufmrvhAyt5a cnhomv ctnahnmv mV•ma rmv mh.snmcahnhma lv am•rynmA.mwah.c. hAtvcAv. •o
enaracen4mrv••v nhhomr3hte3Aesvahd
1dNywcyEyvy. c
Dvwn m.ta2234mvdsdm.tmvdwdm aUvrm. hnAm.-macAv. dmBytaAv. pmIf…ed1icosAc wio3nAU










???




?

?

?????
€
?

?

???????




…




???????

?

wygnyayirsiegpgnaicrpeEoxaoythvPadracg’rpaioaoh--vrsrpeEoxaeta-)rcpipeaAtsrpaipPaAy kngc‘ipisclst-uaulc‘-FFi(b
Firrst-g-tenaoi
Firrst-srge-nFi
ao
 -ie(ir‘-(Ti-ygpc-se-(Ti-
psi(l-s‘-tge’ir(ip-se-(Ti-u)S-se(g-dirrgA‘-
srge-nFi
+o l-vTstT-s‘-my‘gryip-se(g-(Ti-
fAtg‘mh-tihh‘-yc-mt(s’i-(rme‘zgr(-mep-
drgf-(Tieti-se(g-(Ti-zhm‘fm--
)e-(Ti-zhm‘fml-srge-s‘-ygAep-(g-
(rme‘dirrse-mep-fg‘(-s‘-A‘ip--
se-ryt-,ieirm(sge-se-(Ti-
-ygei-fmrrgv
awf,
awf,
)rge-s‘-‘(grip-m‘-dirrs(se-gr-Tmifg‘spirsel-fmsehc-se-fgegeAthimr-zTm,gtc(i‘-nfez -mep-hs’ir
+Ef,+Ef,
STi-ygpc-tmeeg(-ixtri(i-srge-yA(-Pf,-zir-pmc-s‘-hg‘(-fmsehc-
(TrgA,T-‘hgA,Tse,-gd-dirrs(sektge(msese,-u)S-fAtg‘mh-tihh‘
bf,
Dgei-fmrrgv2----------------
se-ryt-zritAr‘gr‘-
nPffwf, 
Lowerwso wbldddguc
ƒan w(ce bsebsM  i
HTms(owsik.
‚Tm
AennPonslH‚)Tmu
„c wonsebssTb(
slH)))Tmuss
…2knTkslfTmu
lyw bsens(wonobcsebsT. m2 aebIsebsr.c rtw Tonskbis ctowsob†.Tonu
-o

‚ƒ„…p017 5hH• D0
R&D 7e Ch 50, p 663; D&H 2e Ch 34, p 116
R&DD 7eCh750e&Dh7,0p5 70,7R&D 7eCh 50,pDe63D,; 6R&D 7eC
h5R
 

0, e &p,63C;
 H;; p,e& 663
  ­
RH2;4C;6;1;&DC
  
€
7‚C673&4&1H0Dh7C1 7D042hp71 e&0467

Patien srd srdonoatien s ih-c
uamesa.-ehdTesmemdT
ktamesesmeldy
Antgf
Patien srdsto shrnt-riscngschternbsrdstol-regsor-urn sblbt u
Patienie asrdioho-csrg
aeiberoluPm.T
kiensiohsr
yrnoiseil sn‘sn-it
Patienie asr
mol-reg
P
u
P

Ppon-Sehscble1lI-iSeatfi-noc,l
 ienosrc,l1-n2lPS-c-hlbon-SehsIli-no
.t ena-h-b‘c
Patiesf
laeiberoc
. Trtol-rken 
-Incler
ioho-coc
sclioho-cof
unasIqoilhsroclbo-r
gio-noil4‘-rnsntT
(-iSsb-)eho

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&MLCKa2+GAsc
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh13,p6138
-
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis
•govyish)yi(g•
e,nuncxv
6,•
0••
etvvxghdncnGg
ly)t)gT(twgh hyihbhB
Tntohn-gigo(
•Ttoy(,nunct)h(in)(
h;•&h
€h;&h;•&h3Ch
dyivnuh,yio
‚y)xvh)gixugxv









 
 
 
­
­€€‚
ƒ „
­€…€‚
­
€
€

 †

‚„ ‚€
‚†‚
‡ˆ†

‰‚ 















 ­

€‚

•LLLoL•€g•kkokv D.gkmoLkk,LL
fbupbko
fbu
pkobLkD.DfbgLDbDbbLumDvooD,D.hCvv
bLvfbD,gLulD,gLLDbvvv,DDD,
LL.DvbDLDD.vfbEouhbDk,oDbvD
•u.uD.D•u•••u
fb•kDuku g-•DulD,DoLDDfbvbbD• DD
DD•DvL€vbv,fDbDkD,LD,DDfDbDu
ufpfkoLmD.DDv‚,bvDfoDƒLk,fb„D.Df.D,
,bvDbkDDuCbffDv••bffD,LbD.
DbDbfu
D.LLkLgL…D†bof,vDu

?







   
?
­   
€ ‚ƒ„

+–disdplpdace NdilA2cAAc–l2.

Smoth us
βα
Smotho u oscl
 idce–NcA2
βα
cl
β

βα
 NAe




Smoth ushmcltetsh
NA2 is1Ai sdp
+
+
+
+
1piAl 
1piAl 
Smoth musoc
pe isp–dNAec
2–dlepe ad
+
+
1peAadadc


1lep–lNAec displace NA
Smoth u



+

+
dc s
+
+
p–l2sda2NA

β
2
α
1
β
1
Smooth muscle cell S SS
↑β



+




Smoth uscl

R&,5&D 505e 50,pe63,Ch5h50
R&D 7eCh&570,pR&D 7eCDh50, p&6 3;,H&26&2;40h1C7 

6 ,750p


3;6
R&D 7eCh570,p 

 ­€‚ ƒ
HC707 eCh2pD
„  …†
‡ˆ ‰ 
Š
641DpDhDD ,p
„
‹
‚   
Œ Ž
‹
 ‚ ; 

???


fb
ufpfkoL
D.LLkLgL

fbuuubpkboLDbb.
gbfmbbmbmbmofmbLbmfbmvLf,fLbfbmfmbfL
vLmfbbpfLbhbmfmbmbmCfLbvmLbLfLmbfLboLDblf
gbfmbf


 
­
????
…†‡ˆ
‡ˆ
‰­Š
‡

Simple dpagraogodm ldif dpagpbgolfsmyi f‘fidfgidiroSimtW
Simple diagram of absorption and distribution of a drug
What is meant by the term ‘bioavailability’?
Passage across the
blood–brain barrier
Absorption across the
mucosa of the intestine 
Passive reabsorption
from the renal tubules
Penetration
into cells
Drug administration Drug eliminationDrug in plasma
Drug in peripheral
tissues
Drug in brain
Lipid solubility
and ionisation
Routes of
administration
Lipid solubility
and ionisation







f••••••
•••f•• •

• • 
-•f• •€‚
ƒ„…†

G-protrerinNCiN5pt n5b5ordtgdwastbim5lrpr5ei1G-prot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
7
ibn5oopdei -CsiToeTlp

????
??
???
inG
? ??
?? ?
???????? ?
? ?? ????
NCrtr-5CHTe 
? ????
??

Gbd ge H w -pe
???
?? ??
??????
?
?
GaesmrepgaslCr1
? ?
?
7
? ?
?
7
?
7
?
7
?
7
α
β β

To

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o

G-protrerinNCiN5pt 35b5ordtgdwastoil-4wm5lrpr5ei6td-m5lrpr5ei1HT -btot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
b
ibn5oopdei -CsiToeTlp
ffmm)uffmm)f/RfT)fx
T/mu••(u•••m/TxP
tnpidC3p-iN•iTob-p5epeiTCoTe5tTCoiC itnpi3p5ad i25eTbidCb5d
5o5petnptTbi••-•g
inG
€ ‚
ƒ   
NCrtr-5CHTe 
­ „ƒ …­
-CNTr5b5Topidpeeib5-lTCtC…Tbg•
Gbd ge H w -pe
†  ‡ˆ‰ 
   † 
­†
‰gˆ
iŠ‹Œng
GaesmrepgaslCr1
Ž ‘

7
Ž 
wi7i•
7
iiiiiw•
7
wi7i•
7
iiiiiw•
7
α
β β

To

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o



























DbDfDfE
//fDfDfS
g•

mfE
ff•••fS
g•
mfE
mD•/fE
DbDfDfE
Db/f•S
••

• 
-
Db/f•S
DbDfDfE
DmD
/fS
•€
-
••
-
•D
m
g

mfEb•DE
ff•••fS








 ­€‚
ƒ

„…‚ †‡ 
­

ˆ‰

Œ Ž

phsfrfhtffhthld
The mo st uf l dfun ehi st ‘f ll ’f.’d
The most useful defnition is ‘Se cardadrS1d6cd.cSe c02i161bS r 2c2db cSe0Scr 0ue bcSe cbpbS i1ucu1ruof0S1d6’.
Incomplete release from the dosage form, destruction within the gut, poor absorption and frst-pass elimination 
are important causes of low bioavailability. For drugs with a low therapeutic index it is important that repeat 
prescriptions provide medicines of equivalent bioavailability (bioequivalence).
n0rS10fc0,bdraS1d6
-Low lipid solubility.
-Ionisation.
-Complexation with
 gut contents (e.g.
 tetracycline/Ca
2+ salts)
-Rapid loss from gut
(diarrhoea).
s bSrouS1d6c16ctoSm
Peptides and proteins
subject to proteolytic
enzymes. Some drugs
acid labile.
l S0,df1bic,pctoScioudb0
drcf1C rc16cxhrbSca0bb:T
90% or more of a drug
dose may be metabolised
during its frst passage
through the liver.
Only a fraction of
dose may reach
general circulation
srotc.driof0S1d6: the
main factor determining
diferences between
preparations.
Drug in solution
in the gut
Disintegration and
dissolution of tablet
s10tr0icbedX16tc.0uSdrbc16Ao 6u16tc,1d0C01f0,1f1Sp

?
































R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&Goboh,nfdnAscƒ
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
prexrfn,TtmmtInb,fuNcrmbdn,rS
srSNr,hn,A
,bether,reAnN
n,cnGnInb,
srSNr,hn,A
SrebIb,reAnNu
r,drRctgn,reAnN
n,cnGnInb,
prvebRtIcnNfRtn,
CgvItmtIru
SvGSIt,Nrfl
lebSItAgt,hn,S
•,R,
r,drRctgn,
fRn,tgfNbeh
R&DCh
lrenRcrei

Pethidine, fentanyl
Pethidine, fentanyl
Methadone,
propoxyphene
Methadone,
propoxyphene
Tramadol
Tramadol
Ibuprofen
Naloxone Morphine, diamorphine,
buprenorphine, codeine
Sensory cortex
Thalamus
PAG
NRM
Tissue damage
Nociceptive C or A B
pain aferent
Spinothalamic tract
neuron
Interneuron in
dorsal horn
Morphine, diamorphine,
buprenorphine, codeine
Amitriptyline
Carbamazepine
Locus ceruleus

R&D 7 eCh5C,p&D6pC0&0 7&,R&D?
R&D 7eCh5, &p,h68hC&1;&H,82D&,4;e 5,14&1;&h&ChCCh0,h4& e00
R&D 77eCh5,p7
6&D8p71;
D epHD&&&D




?
eCHD;p7h,
?
;p7h,D
?
?
?????
???????
???????
??????
?????
??????
?D?????
?D?????
??D?????
?????
R , 01H,8D ˆ-•‰

+Acts Ason,anueg sos umgegv+Aci
+Actsc on,oaueo cAgoacsteaio,nsocgaAvcgvesorsMtoauescm–o
+Actst ton,aAouenata
gtivorMmnvut na
–nvActivorMmnvut na
oAsna
+rcton,aAouenata

ucoanc,snaanonc,ctivavsm
g
+cvuntoa gnMnuvca
•tMcvurirmna
•tamuto,Mcvaa•
mto•a,– ,auco a
–vnmunimuc Are
touncMmuna,•,Mcvaa•mto•a
•mnvsAMto
 sna,–
 mrvcvrcMtm,toetitua
 -•+,aAouenata
+nouvauuto
sncMuvrcton
toetitu,rcton,•,ctiv•
orMmnvut n,aAouenata
•nuevucnun
toetitua,rcton,aAouenata,
o , -•+,aAouenata
•Auciton
toetitua,– ,aAouenata

“ogfƒ‹bmvof,ffgbhoggfE••D.oD.E
fbu


fb
ufpfkoL
D.LLkLgL







  
­ €‚
ƒ „

????????
R&D 7e Ch 24, p 304- D&5 ;e Ch 2H, p 08
R&D 7eC
h2R
R4C,p CD3 4,0- 5
;- e &H-89C
D.LLkLgL
R&D 7eCh &24& e&,



;C3537D4C2

 ­

€‚ƒƒ
ƒƒƒƒ
?
???
??
??????
??
???


‚






















?












? ?




??




SvailtP3– ehmikMv eyphpccpyvtympathmeiptcvt0eymvbrpMpctivPik0nvtM phpccpy)n Mbeiettem
Sympatphepicvp0p–6a+pmy3p6tphepMavp00pbcarbcn
Sympathmheyicvh0pat–ata6v+hp3vmaiiv+yiiv6M0p3a6h6vh0vehbheh0rvnympathy Sympath
Sh0e6vpovy0evh03hnhp6vp3ava0lM(avp3ypvmto66Vih0)6vp3av4a4pheavm3yh0vo–vp3av0a+iMv–ot(aevPnkhieh0rv
niom)6dvpovp3av4a4pheoriMmy0vmaiiv+yiivnym)no0a vv
eiS
sty(V0aryphbavnympathyvy6v+aiivy6v6pta4pomommyiFvro0omommyiFv(a0h0romommyivh0–ampho06Fvy0p3ty2Fv
eh4p3p3athyFvry6vry0rta0a v
cvptpy0v–6h+
uM4at6a06hphbhpMvtaympho06v1ty63a6FvktphmythyFvy0rhoaea(yFv–abatFvytp3tyirhyFvy0y43Miy2h6Rcvs• v
eh6pktny0ma6cvtytaiMvmoihph6 v
S3M+bh+–+r+ymh
shba0vh ( votvh b votvnMv6io+vh b vh0–k6ho0 v-y66a6vh0povyiivnoeMv€khe6cva2mtapaevh0vp3avkth0av1niom)aevnMv
4tona0amheR v‚(4hmhiih0vh6vrhba0vh b v
Snh ophmbn lvp(
V+hphm0ty+ƒopva„amphbavyryh06pv6py43Miomommhv1ekavpovSViympy(y6aRvy0evpov6pta4pomommhv+3hm3v3ybavh(4yhtaev
SViympy(vnh0eh0rvekavpov(kpypho0vo–vp3avpty064a4phey6ava0lM(a 
)4+yp0v–4aptmh•0ymphbypaevnMvnympathyivSViympy(y6a6cvk6kyiiMvrhba0v+hp3vmiybkiy0hmvymhev+3hm3vh03hnhp6v SViympy(y6a6 v

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&.g hn dhGw toAsc‚
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis

R&D 7e7C&h24&CD,Cp3
R&D 7e7C&h24&CD,Cp3
0&D ,e;C&h
H5;H;8pH &C&
0&D ,e;C&h
H5;H;8pH &C&
-5,9,e;3
-5,9,e;3
H5;4&C
)bpmwmti 0;5H 7C&h2e7,9;5H 7C&h
yklgitmgldstioa,m isti
vit.mgea,mgniw
fdbpbck.
BGI
)Tr
fs..kia bcbui
)m,s,ilnsxiazamgaGaB
lbstab•igitn
vlstmndbpbcs,angb,n
tikgmt
(tnigtikgmtast
 mg.bpadmgt
rmgldstioa sbcmgldstio
yklgitmgldstioa,m isti
Bindisi toaht
•m,k.a,igkpik.

ReaoftFrtiidea pitf (.r etpr.Fdahon Fdoe )Aoloudr frpcg e.raroFa-uoetmy(t dtu bFtio
Reductuioun furupa hude.uatuiounafuru(F
Reduction of neuropathic pain. (For antidepressant action see set 24).Reducti
Analgesic action of antidepressants is mainly due to inhibition of the opening of neuronal 
voltage-gated Na

channels (Na
v
 1.7 subtype) rather than to inhibition of monoamine reuptake. Na
+
 
channel block reduces pain transmission from site of nerve injury. 
onR
Postherpetic neuralgia, diabetic peripheral neuropathy, neuropathic cancer pain. futuerfpaih
Sedation (antihistamine action, less with nortriptyline). Blurred vision, dry mouth, constipation,
urinary retention (antimuscarinic action). Postural hypotension (R
1
-adrenoceptor antagonism).
Overdose potentially fatal due to cardiac dysrhythmia, severe hypotension, seizure and CNS
depression. Increased risk of suicide in young patients. 
R.(hFihphshedi
Oral administration. Hepatic P450 metabolism (nortriptyline is a metabolite of amitriptyline).
T
0.5
 12–24h.
R2i4)uidF24Aful

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&Goboh,nfdnAscƒ
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
prexrfn,TtmmtInb,fuNcrmbdn,rS
srSNr,hn,A
,bether,reAnN
n,cnGnInb,
srSNr,hn,A
SrebIb,reAnNu
r,drRctgn,reAnN
n,cnGnInb,
prvebRtIcnNfRtn,
CgvItmtIru
SvGSIt,Nrfl
lebSItAgt,hn,S
•,R,
r,drRctgn,
fRn,tgfNbeh
R&DCh
lrenRcrei

Pethidine, fentanyl
Pethidine, fentanyl
Methadone,
propoxyphene
Methadone,
propoxyphene
Tramadol
Tramadol
Ibuprofen
Naloxone Morphine, diamorphine,
buprenorphine, codeine
Sensory cortex
Thalamus
PAG
NRM
Tissue damage
Nociceptive C or A B
pain aferent
Spinothalamic tract
neuron
Interneuron in
dorsal horn
Morphine, diamorphine,
buprenorphine, codeine
Amitriptyline
Carbamazepine
Locus ceruleus

G-protrerinNCiN5pt n5b5ordtgdwastbim5lrpr5ei1G-prot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
7
ibn5oopdei -CsiToeTlp

????
??
???
inG
? ??
?? ?
???????? ?
? ?? ????
NCrtr-5CHTe 
? ????
??

Gbd ge H w -pe
???
?? ??
??????
?
?
GaesmrepgaslCr1
? ?
?
7
? ?
?
7
?
7
?
7
?
7
α
β β

To

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o

G-protrerinNCiN5pt 35b5ordtgdwastoil-4wm5lrpr5ei6td-m5lrpr5ei1HT -btot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
b
ibn5oopdei -CsiToeTlp
ffmm)uffmm)f/RfT)fx
T/mu••(u•••m/TxP
tnpidC3p-iN•iTob-p5epeiTCoTe5tTCoiC itnpi3p5ad i25eTbidCb5d
5o5petnptTbi••-•g
inG
€ ‚
ƒ   
NCrtr-5CHTe 
­ „ƒ …­
-CNTr5b5Topidpeeib5-lTCtC…Tbg•
Gbd ge H w -pe
†  ‡ˆ‰ 
   † 
­†
‰gˆ
iŠ‹Œng
GaesmrepgaslCr1
Ž ‘

7
Ž 
wi7i•
7
iiiiiw•
7
wi7i•
7
iiiiiw•
7
α
β β

To

Fre ff atyrc ric ratdtre ff aysCcisELpcT ratLyEac LVrapm2HHe D73heHR&HH
Fre fatye cridc sre fCEL pesEoiLnl VEsrdED nC sre VyiTtlsniC iG tynl ElnT
R&D 7Fre faetyetcaeyiadsdy fCtFyEeyLefdFCepCF 
oap FEnetyepdtcdFtFre faetye asyrFtFyEeyLefdpta
CdlrtporeFEetcaeVyFEtrDeTcpnyCltareaEnfoLetca
CdlrtporepE edaoapraeFEGp>>ptydle>a FptydrDe
ehmTHbvA(hwA)
bvA(hwA)
>ynl ElnT
bpEtcFEaeyuF pra
bpEtcFEaeyuF pra

FPouGuGplmuGmyh9LŽ‘iLaglatGgmhlh9Luagga•mgGmyhtyPLaOloySLHLySrn
R&D 7e Ch 29, p 367; D&H 2e Ch 27, p 67
FSHLySpoLthaSMA, monaieDdemopnAiApn,em,pnDoenaeoDpeAapmNrna Al5e-nH elDaAaeTaAledDheomTaAmemoleyDinpnoHeDd
, AiDp AhmxteOAax5e,naxrmpnos5ecAoAhmrrteTaAlenoe,DiNnompnDoeunp eDp AhemopnAiApn,a5e
lLaaLmuahustf,pnDoeynmeb/
g
ehA,AxpDha5evaAledDheomTaAmemoleyDinpnoHemaaD,nmpAleunp e,mo,Ahe, AiDp Ahmxt5e
ShDomNnoDrenaep Aeimnoem,pnyAenoHhAlnAopeOpAphm tlhD,moomNnoDrseDde,moomNnaReomNnrDoAenaemeatop Apn,
momrDHTA5eMmte,mTaAelAxAolAo,A5ewmNnrDoAenaeem,pnyAeNteiDTp Ref
 5-
e€ 5
PSerhiuaua
rS SOphr
LapLghautpt
‚5H5emxhAxnpmopeNrD,ƒaeaTNapmo,Ae„ehA,AxpDhaenoep AeyDinpnoHe,AophA5efl…To,pedDhephAmpiAopeDd
, AiDp Ahmxt†nolT,AleemolexDap†DxAhmpnyAeomTaAmemoleyDinpnoH5e‡hmrrtem,pnyA5
MApmNDrnaAleNte,tpD, hDiAe„ˆ- eatapAienoernyAh5ef
 5-
eg€ 5

????????
R&D 7e Ch 24, p 304- D&5 ;e Ch 2H, p 08
R&D 7eC
h2R
R4C,p CD3 4,0- 5
;- e &H-89C
D.LLkLgL
R&D 7eCh &24& e&,



;C3537D4C2

 ­

€‚ƒƒ
ƒƒƒƒ
?
???
??
??????
??
???


????????
R&D 7e Ch 24, p 304- D&5 ;e Ch 2H, p 08
R&D 7eC
h2R
R4C,p CD3 4,0- 5
;- e &H-89C
D.LLkLgL
R&D 7eCh &24& e&,



;C3537D4C2

 ­

€‚ƒƒ
ƒƒƒƒ
?
???
??
??????
??
???


‚






















?












? ?




??




‚






















?












? ?




??




SvailtP3– ehmikMv eyphpccpyvtympathmeiptcvt0eymvbrpMpctivPik0nvtM phpccpy)n Mbeiettem
Sympatphepicvp0p–6a+pmy3p6tphepMavp00pbcarbcn
Sympathmheyicvh0pat–ata6v+hp3vmaiiv+yiiv6M0p3a6h6vh0vehbheh0rvnympathy Sympath
Sh0e6vpovy0evh03hnhp6vp3ava0lM(avp3ypvmto66Vih0)6vp3av4a4pheavm3yh0vo–vp3av0a+iMv–ot(aevPnkhieh0rv
niom)6dvpovp3av4a4pheoriMmy0vmaiiv+yiivnym)no0a vv
eiS
sty(V0aryphbavnympathyvy6v+aiivy6v6pta4pomommyiFvro0omommyiFv(a0h0romommyivh0–ampho06Fvy0p3ty2Fv
eh4p3p3athyFvry6vry0rta0a v
cvptpy0v–6h+
uM4at6a06hphbhpMvtaympho06v1ty63a6FvktphmythyFvy0rhoaea(yFv–abatFvytp3tyirhyFvy0y43Miy2h6Rcvs• v
eh6pktny0ma6cvtytaiMvmoihph6 v
S3M+bh+–+r+ymh
shba0vh ( votvh b votvnMv6io+vh b vh0–k6ho0 v-y66a6vh0povyiivnoeMv€khe6cva2mtapaevh0vp3avkth0av1niom)aevnMv
4tona0amheR v‚(4hmhiih0vh6vrhba0vh b v
Snh ophmbn lvp(
V+hphm0ty+ƒopva„amphbavyryh06pv6py43Miomommhv1ekavpovSViympy(y6aRvy0evpov6pta4pomommhv+3hm3v3ybavh(4yhtaev
SViympy(vnh0eh0rvekavpov(kpypho0vo–vp3avpty064a4phey6ava0lM(a 
)4+yp0v–4aptmh•0ymphbypaevnMvnympathyivSViympy(y6a6cvk6kyiiMvrhba0v+hp3vmiybkiy0hmvymhev+3hm3vh03hnhp6v SViympy(y6a6 v

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&.g hn dhGw toAsc‚
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis

R&D 7e7C&h24&CD,Cp3
R&D 7e7C&h24&CD,Cp3
0&D ,e;C&h
H5;H;8pH &C&
0&D ,e;C&h
H5;H;8pH &C&
-5,9,e;3
-5,9,e;3
H5;4&C
)bpmwmti 0;5H 7C&h2e7,9;5H 7C&h
yklgitmgldstioa,m isti
vit.mgea,mgniw
fdbpbck.
BGI
)Tr
fs..kia bcbui
)m,s,ilnsxiazamgaGaB
lbstab•igitn
vlstmndbpbcs,angb,n
tikgmt
(tnigtikgmtast
 mg.bpadmgt
rmgldstioa sbcmgldstio
yklgitmgldstioa,m isti
Bindisi toaht
•m,k.a,igkpik.

ReaoftFrtiidea pitf (.r etpr.Fdahon Fdoe )Aoloudr frpcg e.raroFa-uoetmy(t dtu bFtio
Reductuioun furupa hude.uatuiounafuru(F
Reduction of neuropathic pain. (For antidepressant action see set 24).Reducti
Analgesic action of antidepressants is mainly due to inhibition of the opening of neuronal 
voltage-gated Na

channels (Na
v
 1.7 subtype) rather than to inhibition of monoamine reuptake. Na
+
 
channel block reduces pain transmission from site of nerve injury. 
onR
Postherpetic neuralgia, diabetic peripheral neuropathy, neuropathic cancer pain. futuerfpaih
Sedation (antihistamine action, less with nortriptyline). Blurred vision, dry mouth, constipation,
urinary retention (antimuscarinic action). Postural hypotension (R
1
-adrenoceptor antagonism).
Overdose potentially fatal due to cardiac dysrhythmia, severe hypotension, seizure and CNS
depression. Increased risk of suicide in young patients. 
R.(hFihphshedi
Oral administration. Hepatic P450 metabolism (nortriptyline is a metabolite of amitriptyline).
T
0.5
 12–24h.
R2i4)uidF24Aful

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&Goboh,nfdnAscƒ
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
prexrfn,TtmmtInb,fuNcrmbdn,rS
srSNr,hn,A
,bether,reAnN
n,cnGnInb,
srSNr,hn,A
SrebIb,reAnNu
r,drRctgn,reAnN
n,cnGnInb,
prvebRtIcnNfRtn,
CgvItmtIru
SvGSIt,Nrfl
lebSItAgt,hn,S
•,R,
r,drRctgn,
fRn,tgfNbeh
R&DCh
lrenRcrei

Pethidine, fentanyl
Pethidine, fentanyl
Methadone,
propoxyphene
Methadone,
propoxyphene
Tramadol
Tramadol
Ibuprofen
Naloxone Morphine, diamorphine,
buprenorphine, codeine
Sensory cortex
Thalamus
PAG
NRM
Tissue damage
Nociceptive C or A B
pain aferent
Spinothalamic tract
neuron
Interneuron in
dorsal horn
Morphine, diamorphine,
buprenorphine, codeine
Amitriptyline
Carbamazepine
Locus ceruleus

G-protrerinNCiN5pt n5b5ordtgdwastbim5lrpr5ei1G-prot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
7
ibn5oopdei -CsiToeTlp

????
??
???
inG
? ??
?? ?
???????? ?
? ?? ????
NCrtr-5CHTe 
? ????
??

Gbd ge H w -pe
???
?? ??
??????
?
?
GaesmrepgaslCr1
? ?
?
7
? ?
?
7
?
7
?
7
?
7
α
β β

To

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o

G-protrerinNCiN5pt 35b5ordtgdwastoil-4wm5lrpr5ei6td-m5lrpr5ei1HT -btot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
b
ibn5oopdei -CsiToeTlp
ffmm)uffmm)f/RfT)fx
T/mu••(u•••m/TxP
tnpidC3p-iN•iTob-p5epeiTCoTe5tTCoiC itnpi3p5ad i25eTbidCb5d
5o5petnptTbi••-•g
inG
€ ‚
ƒ   
NCrtr-5CHTe 
­ „ƒ …­
-CNTr5b5Topidpeeib5-lTCtC…Tbg•
Gbd ge H w -pe
†  ‡ˆ‰ 
   † 
­†
‰gˆ
iŠ‹Œng
GaesmrepgaslCr1
Ž ‘

7
Ž 
wi7i•
7
iiiiiw•
7
wi7i•
7
iiiiiw•
7
α
β β

To

SvailtP3– ehmikMv eyphpccpyvtympathmeiptcvt0eymvbrpMpctivPik0nvtM phpccpy)n Mbeiettem
Sympatphepicvp0p–6a+pmy3p6tphepMavp00pbcarbcn
Sympathmheyicvh0pat–ata6v+hp3vmaiiv+yiiv6M0p3a6h6vh0vehbheh0rvnympathy Sympath
Sh0e6vpovy0evh03hnhp6vp3ava0lM(avp3ypvmto66Vih0)6vp3av4a4pheavm3yh0vo–vp3av0a+iMv–ot(aevPnkhieh0rv
niom)6dvpovp3av4a4pheoriMmy0vmaiiv+yiivnym)no0a vv
eiS
sty(V0aryphbavnympathyvy6v+aiivy6v6pta4pomommyiFvro0omommyiFv(a0h0romommyivh0–ampho06Fvy0p3ty2Fv
eh4p3p3athyFvry6vry0rta0a v
cvptpy0v–6h+
uM4at6a06hphbhpMvtaympho06v1ty63a6FvktphmythyFvy0rhoaea(yFv–abatFvytp3tyirhyFvy0y43Miy2h6Rcvs• v
eh6pktny0ma6cvtytaiMvmoihph6 v
S3M+bh+–+r+ymh
shba0vh ( votvh b votvnMv6io+vh b vh0–k6ho0 v-y66a6vh0povyiivnoeMv€khe6cva2mtapaevh0vp3avkth0av1niom)aevnMv
4tona0amheR v‚(4hmhiih0vh6vrhba0vh b v
Snh ophmbn lvp(
V+hphm0ty+ƒopva„amphbavyryh06pv6py43Miomommhv1ekavpovSViympy(y6aRvy0evpov6pta4pomommhv+3hm3v3ybavh(4yhtaev
SViympy(vnh0eh0rvekavpov(kpypho0vo–vp3avpty064a4phey6ava0lM(a 
)4+yp0v–4aptmh•0ymphbypaevnMvnympathyivSViympy(y6a6cvk6kyiiMvrhba0v+hp3vmiybkiy0hmvymhev+3hm3vh03hnhp6v SViympy(y6a6 v

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&.g hn dhGw toAsc‚
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis

R&D 7e7C&h24&CD,Cp3
R&D 7e7C&h24&CD,Cp3
0&D ,e;C&h
H5;H;8pH &C&
0&D ,e;C&h
H5;H;8pH &C&
-5,9,e;3
-5,9,e;3
H5;4&C
)bpmwmti 0;5H 7C&h2e7,9;5H 7C&h
yklgitmgldstioa,m isti
vit.mgea,mgniw
fdbpbck.
BGI
)Tr
fs..kia bcbui
)m,s,ilnsxiazamgaGaB
lbstab•igitn
vlstmndbpbcs,angb,n
tikgmt
(tnigtikgmtast
 mg.bpadmgt
rmgldstioa sbcmgldstio
yklgitmgldstioa,m isti
Bindisi toaht
•m,k.a,igkpik.

ReaoftFrtiidea pitf (.r etpr.Fdahon Fdoe )Aoloudr frpcg e.raroFa-uoetmy(t dtu bFtio
Reductuioun furupa hude.uatuiounafuru(F
Reduction of neuropathic pain. (For antidepressant action see set 24).Reducti
Analgesic action of antidepressants is mainly due to inhibition of the opening of neuronal 
voltage-gated Na

channels (Na
v
 1.7 subtype) rather than to inhibition of monoamine reuptake. Na
+
 
channel block reduces pain transmission from site of nerve injury. 
onR
Postherpetic neuralgia, diabetic peripheral neuropathy, neuropathic cancer pain. futuerfpaih
Sedation (antihistamine action, less with nortriptyline). Blurred vision, dry mouth, constipation,
urinary retention (antimuscarinic action). Postural hypotension (R
1
-adrenoceptor antagonism).
Overdose potentially fatal due to cardiac dysrhythmia, severe hypotension, seizure and CNS
depression. Increased risk of suicide in young patients. 
R.(hFihphshedi
Oral administration. Hepatic P450 metabolism (nortriptyline is a metabolite of amitriptyline).
T
0.5
 12–24h.
R2i4)uidF24Aful

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&Goboh,nfdnAscƒ
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
prexrfn,TtmmtInb,fuNcrmbdn,rS
srSNr,hn,A
,bether,reAnN
n,cnGnInb,
srSNr,hn,A
SrebIb,reAnNu
r,drRctgn,reAnN
n,cnGnInb,
prvebRtIcnNfRtn,
CgvItmtIru
SvGSIt,Nrfl
lebSItAgt,hn,S
•,R,
r,drRctgn,
fRn,tgfNbeh
R&DCh
lrenRcrei

Pethidine, fentanyl
Pethidine, fentanyl
Methadone,
propoxyphene
Methadone,
propoxyphene
Tramadol
Tramadol
Ibuprofen
Naloxone Morphine, diamorphine,
buprenorphine, codeine
Sensory cortex
Thalamus
PAG
NRM
Tissue damage
Nociceptive C or A B
pain aferent
Spinothalamic tract
neuron
Interneuron in
dorsal horn
Morphine, diamorphine,
buprenorphine, codeine
Amitriptyline
Carbamazepine
Locus ceruleus

G-protrerinNCiN5pt n5b5ordtgdwastbim5lrpr5ei1G-prot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
7
ibn5oopdei -CsiToeTlp

????
??
???
inG
? ??
?? ?
???????? ?
? ?? ????
NCrtr-5CHTe 
? ????
??

Gbd ge H w -pe
???
?? ??
??????
?
?
GaesmrepgaslCr1
? ?
?
7
? ?
?
7
?
7
?
7
?
7
α
β β

To

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o

G-protrerinNCiN5pt 35b5ordtgdwastoil-4wm5lrpr5ei6td-m5lrpr5ei1HT -btot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
b
ibn5oopdei -CsiToeTlp
ffmm)uffmm)f/RfT)fx
T/mu••(u•••m/TxP
tnpidC3p-iN•iTob-p5epeiTCoTe5tTCoiC itnpi3p5ad i25eTbidCb5d
5o5petnptTbi••-•g
inG
€ ‚
ƒ   
NCrtr-5CHTe 
­ „ƒ …­
-CNTr5b5Topidpeeib5-lTCtC…Tbg•
Gbd ge H w -pe
†  ‡ˆ‰ 
   † 
­†
‰gˆ
iŠ‹Œng
GaesmrepgaslCr1
Ž ‘

7
Ž 
wi7i•
7
iiiiiw•
7
wi7i•
7
iiiiiw•
7
α
β β

To

Fre ff atyrc ric ratdtre ff aysCcisELpcT ratLyEac LVrapm2HHe D73heHR&HH
Fre fatye cridc sre fCEL pesEoiLnl VEsrdED nC sre VyiTtlsniC iG tynl ElnT
R&D 7Fre faetyetcaeyiadsdy fCtFyEeyLefdFCepCF 
oap FEnetyepdtcdFtFre faetye asyrFtFyEeyLefdpta
CdlrtporeFEetcaeVyFEtrDeTcpnyCltareaEnfoLetca
CdlrtporepE edaoapraeFEGp>>ptydle>a FptydrDe
ehmTHbvA(hwA)
bvA(hwA)
>ynl ElnT
bpEtcFEaeyuF pra
bpEtcFEaeyuF pra

Fre ff atyrc ric ratdtre ff aysCcisELpcT ratLyEac LVrapm2HHe D73heHR&HH
Fre fatye cridc sre fCEL pesEoiLnl VEsrdED nC sre VyiTtlsniC iG tynl ElnT
R&D 7Fre faetyetcaeyiadsdy fCtFyEeyLefdFCepCF 
oap FEnetyepdtcdFtFre faetye asyrFtFyEeyLefdpta
CdlrtporeFEetcaeVyFEtrDeTcpnyCltareaEnfoLetca
CdlrtporepE edaoapraeFEGp>>ptydle>a FptydrDe
ehmTHbvA(hwA)
bvA(hwA)
>ynl ElnT
bpEtcFEaeyuF pra
bpEtcFEaeyuF pra

FPouGuGplmuGmyh9LŽ‘iLaglatGgmhlh9Luagga•mgGmyhtyPLaOloySLHLySrn
R&D 7e Ch 29, p 367; D&H 2e Ch 27, p 67
FSHLySpoLthaSMA, monaieDdemopnAiApn,em,pnDoenaeoDpeAapmNrna Al5e-nH elDaAaeTaAledDheomTaAmemoleyDinpnoHeDd
, AiDp AhmxteOAax5e,naxrmpnos5ecAoAhmrrteTaAlenoe,DiNnompnDoeunp eDp AhemopnAiApn,a5e
lLaaLmuahustf,pnDoeynmeb/
g
ehA,AxpDha5evaAledDheomTaAmemoleyDinpnoHemaaD,nmpAleunp e,mo,Ahe, AiDp Ahmxt5e
ShDomNnoDrenaep Aeimnoem,pnyAenoHhAlnAopeOpAphm tlhD,moomNnoDrseDde,moomNnaReomNnrDoAenaemeatop Apn,
momrDHTA5eMmte,mTaAelAxAolAo,A5ewmNnrDoAenaeem,pnyAeNteiDTp Ref
 5-
e€ 5
PSerhiuaua
rS SOphr
LapLghautpt
‚5H5emxhAxnpmopeNrD,ƒaeaTNapmo,Ae„ehA,AxpDhaenoep AeyDinpnoHe,AophA5efl…To,pedDhephAmpiAopeDd
, AiDp Ahmxt†nolT,AleemolexDap†DxAhmpnyAeomTaAmemoleyDinpnoH5e‡hmrrtem,pnyA5
MApmNDrnaAleNte,tpD, hDiAe„ˆ- eatapAienoernyAh5ef
 5-
eg€ 5

FPouGuGplmuGmyh9LŽ‘iLaglatGgmhlh9Luagga•mgGmyhtyPLaOloySLHLySrn
R&D 7e Ch 29, p 367; D&H 2e Ch 27, p 67
FSHLySpoLthaSMA, monaieDdemopnAiApn,em,pnDoenaeoDpeAapmNrna Al5e-nH elDaAaeTaAledDheomTaAmemoleyDinpnoHeDd
, AiDp AhmxteOAax5e,naxrmpnos5ecAoAhmrrteTaAlenoe,DiNnompnDoeunp eDp AhemopnAiApn,a5e
lLaaLmuahustf,pnDoeynmeb/
g
ehA,AxpDha5evaAledDheomTaAmemoleyDinpnoHemaaD,nmpAleunp e,mo,Ahe, AiDp Ahmxt5e
ShDomNnoDrenaep Aeimnoem,pnyAenoHhAlnAopeOpAphm tlhD,moomNnoDrseDde,moomNnaReomNnrDoAenaemeatop Apn,
momrDHTA5eMmte,mTaAelAxAolAo,A5ewmNnrDoAenaeem,pnyAeNteiDTp Ref
 5-
e€ 5
PSerhiuaua
rS SOphr
LapLghautpt
‚5H5emxhAxnpmopeNrD,ƒaeaTNapmo,Ae„ehA,AxpDhaenoep AeyDinpnoHe,AophA5efl…To,pedDhephAmpiAopeDd
, AiDp Ahmxt†nolT,AleemolexDap†DxAhmpnyAeomTaAmemoleyDinpnoH5e‡hmrrtem,pnyA5
MApmNDrnaAleNte,tpD, hDiAe„ˆ- eatapAienoernyAh5ef
 5-
eg€ 5

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&.g hn dhGw toAsc‚
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis

R&D 7e7C&h24&CD,Cp3
R&D 7e7C&h24&CD,Cp3
0&D ,e;C&h
H5;H;8pH &C&
0&D ,e;C&h
H5;H;8pH &C&
-5,9,e;3
-5,9,e;3
H5;4&C
)bpmwmti 0;5H 7C&h2e7,9;5H 7C&h
yklgitmgldstioa,m isti
vit.mgea,mgniw
fdbpbck.
BGI
)Tr
fs..kia bcbui
)m,s,ilnsxiazamgaGaB
lbstab•igitn
vlstmndbpbcs,angb,n
tikgmt
(tnigtikgmtast
 mg.bpadmgt
rmgldstioa sbcmgldstio
yklgitmgldstioa,m isti
Bindisi toaht
•m,k.a,igkpik.



























DbDfDfE
//fDfDfS
g•

mfE
ff•••fS
g•
mfE
mD•/fE
DbDfDfE
Db/f•S
••

• 
-
Db/f•S
DbDfDfE
DmD
/fS
•€
-
••
-
•D
m
g

mfEb•DE
ff•••fS








Excretion valutengseiDhxiolvg
eocgtedBeasuot
utnBr
Excd
Excretion via lungs
Excretiecion ovtirtar rlnugrviroxcrstlDrvhrnclueclrcvoxcnrsDrvohrdco stBvhdrtnrsDrvohrcyencovtiruiex igcl
Drug in exhaled air
B
i
l
ia
r
y
 e
xcrExcre
tion vExalrucxE EgsiExcre lD hcdeED
BesyaenEd dion EgsiExcr
e
 l
D
 h
c
d
e
E
D
BesyaenEd dion ri
vExalrucxE ce oiceE
tion ri vExalrucxE
ce aEsE
tion vExalrucxE
ce lrdD
cucaiD EgsiExcre
tion ce lrdD
ya E 
ya E 
Dx
Edosxcre
•DdiruD c
Excr
etion va
Excr
etleuegsva
•gcdaxcre
re•onaxcre

5r.my3.avry 2tA3r1eUENh.eAth
Fungalg igfecgttgeoaseok,gnuhgolg igfocgtgaa
1. AtacAhmAenmtn2aEnrmyAntyhdmNahmwah.c. hAtvcA.tmacAv. d1. Atac
i.Amy rnthA..romsa3macAmUatA23m. m1gartn .cnUA.th4mUatA23m. mTgNfmtncnUA.thdhm1
f.mAtnaAmU.hAgUatAysmeans.ttealndenAaA.2nErcy
DufmrvhAyt5a cnhomv ctnahnmv mV•ma rmv mh.snmcahnhma lv am•rynmA.mwah.c. hAtvcAv. •o
enaracen4mrv••v nhhomr3hte3Aesvahd
1dNywcyEyvy. c
Dvwn m.ta2234mvdsdm.tmvdwdm aUvrm. hnAm.-macAv. dmBytaAv. pmIf…ed1icosAc wio3nAU










???




?

?

?????
€
?

?

???????




…




???????

?

wygnyayirsiegpgnaicrpeEoxaoythvPadracg’rpaioaoh--vrsrpeEoxaeta-)rcpipeaAtsrpaipPaAy kngc‘ipisclst-uaulc‘-FFi(b
Firrst-g-tenaoi
Firrst-srge-nFi
ao
 -ie(ir‘-(Ti-ygpc-se-(Ti-
psi(l-s‘-tge’ir(ip-se-(Ti-u)S-se(g-dirrgA‘-
srge-nFi
+o l-vTstT-s‘-my‘gryip-se(g-(Ti-
fAtg‘mh-tihh‘-yc-mt(s’i-(rme‘zgr(-mep-
drgf-(Tieti-se(g-(Ti-zhm‘fm--
)e-(Ti-zhm‘fml-srge-s‘-ygAep-(g-
(rme‘dirrse-mep-fg‘(-s‘-A‘ip--
se-ryt-,ieirm(sge-se-(Ti-
-ygei-fmrrgv
awf,
awf,
)rge-s‘-‘(grip-m‘-dirrs(se-gr-Tmifg‘spirsel-fmsehc-se-fgegeAthimr-zTm,gtc(i‘-nfez -mep-hs’ir
+Ef,+Ef,
STi-ygpc-tmeeg(-ixtri(i-srge-yA(-Pf,-zir-pmc-s‘-hg‘(-fmsehc-
(TrgA,T-‘hgA,Tse,-gd-dirrs(sektge(msese,-u)S-fAtg‘mh-tihh‘
bf,
Dgei-fmrrgv2----------------
se-ryt-zritAr‘gr‘-
nPffwf, 
Lowerwso wbldddguc
ƒan w(ce bsebsM  i
HTms(owsik.
‚Tm
AennPonslH‚)Tmu
„c wonsebssTb(
slH)))Tmuss
…2knTkslfTmu
lyw bsens(wonobcsebsT. m2 aebIsebsr.c rtw Tonskbis ctowsob†.Tonu
-o

‚ƒ„…p017 5hH• D0
R&D 7e Ch 50, p 663; D&H 2e Ch 34, p 116
R&DD 7eCh750e&Dh7,0p5 70,7R&D 7eCh 50,pDe63D,; 6R&D 7eC
h5R
 

0, e &p,63C;
 H;; p,e& 663
  ­
RH2;4C;6;1;&DC
  
€
7‚C673&4&1H0Dh7C1 7D042hp71 e&0467

Patien srd srdonoatien s ih-c
uamesa.-ehdTesmemdT
ktamesesmeldy
Antgf
Patien srdsto shrnt-riscngschternbsrdstol-regsor-urn sblbt u
Patienie asrdioho-csrg
aeiberoluPm.T
kiensiohsr
yrnoiseil sn‘sn-it
Patienie asr
mol-reg
P
u
P

Ppon-Sehscble1lI-iSeatfi-noc,l
 ienosrc,l1-n2lPS-c-hlbon-SehsIli-no
.t ena-h-b‘c
Patiesf
laeiberoc
. Trtol-rken 
-Incler
ioho-coc
sclioho-cof
unasIqoilhsroclbo-r
gio-noil4‘-rnsntT
(-iSsb-)eho

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&MLCKa2+GAsc
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh13,p6138
-
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis
•govyish)yi(g•
e,nuncxv
6,•
0••
etvvxghdncnGg
ly)t)gT(twgh hyihbhB
Tntohn-gigo(
•Ttoy(,nunct)h(in)(
h;•&h
€h;&h;•&h3Ch
dyivnuh,yio
‚y)xvh)gixugxv









 
 
 
­
­€€‚
ƒ „
­€…€‚
­
€
€

 †

‚„ ‚€
‚†‚
‡ˆ†

‰‚ 

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&.g hn dhGw toAsc‚
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis

R&D 7e7C&h24&CD,Cp3
R&D 7e7C&h24&CD,Cp3
0&D ,e;C&h
H5;H;8pH &C&
0&D ,e;C&h
H5;H;8pH &C&
-5,9,e;3
-5,9,e;3
H5;4&C
)bpmwmti 0;5H 7C&h2e7,9;5H 7C&h
yklgitmgldstioa,m isti
vit.mgea,mgniw
fdbpbck.
BGI
)Tr
fs..kia bcbui
)m,s,ilnsxiazamgaGaB
lbstab•igitn
vlstmndbpbcs,angb,n
tikgmt
(tnigtikgmtast
 mg.bpadmgt
rmgldstioa sbcmgldstio
yklgitmgldstioa,m isti
Bindisi toaht
•m,k.a,igkpik.

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&.g hn dhGw toAsc‚
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis

R&D 7e7C&h24&CD,Cp3
R&D 7e7C&h24&CD,Cp3
0&D ,e;C&h
H5;H;8pH &C&
0&D ,e;C&h
H5;H;8pH &C&
-5,9,e;3
-5,9,e;3
H5;4&C
)bpmwmti 0;5H 7C&h2e7,9;5H 7C&h
yklgitmgldstioa,m isti
vit.mgea,mgniw
fdbpbck.
BGI
)Tr
fs..kia bcbui
)m,s,ilnsxiazamgaGaB
lbstab•igitn
vlstmndbpbcs,angb,n
tikgmt
(tnigtikgmtast
 mg.bpadmgt
rmgldstioa sbcmgldstio
yklgitmgldstioa,m isti
Bindisi toaht
•m,k.a,igkpik.



























DbDfDfE
//fDfDfS
g•

mfE
ff•••fS
g•
mfE
mD•/fE
DbDfDfE
Db/f•S
••

• 
-
Db/f•S
DbDfDfE
DmD
/fS
•€
-
••
-
•D
m
g

mfEb•DE
ff•••fS








Excretion valutengseiDhxiolvg
eocgtedBeasuot
utnBr
Excd
Excretion via lungs
Excretiecion ovtirtar rlnugrviroxcrstlDrvhrnclueclrcvoxcnrsDrvohrdco stBvhdrtnrsDrvohrcyencovtiruiex igcl
Drug in exhaled air
B
i
l
ia
r
y
 e
xcrExcre
tion vExalrucxE EgsiExcre lD hcdeED
BesyaenEd dion EgsiExcr
e
 l
D
 h
c
d
e
E
D
BesyaenEd dion ri
vExalrucxE ce oiceE
tion ri vExalrucxE
ce aEsE
tion vExalrucxE
ce lrdD
cucaiD EgsiExcre
tion ce lrdD
ya E 
ya E 
Dx
Edosxcre
•DdiruD c
Excr
etion va
Excr
etleuegsva
•gcdaxcre
re•onaxcre



























DbDfDfE
//fDfDfS
g•

mfE
ff•••fS
g•
mfE
mD•/fE
DbDfDfE
Db/f•S
••

• 
-
Db/f•S
DbDfDfE
DmD
/fS
•€
-
••
-
•D
m
g

mfEb•DE
ff•••fS








Excretion valutengseiDhxiolvg
eocgtedBeasuot
utnBr
Excd
Excretion via lungs
Excretiecion ovtirtar rlnugrviroxcrstlDrvhrnclueclrcvoxcnrsDrvohrdco stBvhdrtnrsDrvohrcyencovtiruiex igcl
Drug in exhaled air
B
i
l
ia
r
y
 e
xcrExcre
tion vExalrucxE EgsiExcre lD hcdeED
BesyaenEd dion EgsiExcr
e
 l
D
 h
c
d
e
E
D
BesyaenEd dion ri
vExalrucxE ce oiceE
tion ri vExalrucxE
ce aEsE
tion vExalrucxE
ce lrdD
cucaiD EgsiExcre
tion ce lrdD
ya E 
ya E 
Dx
Edosxcre
•DdiruD c
Excr
etion va
Excr
etleuegsva
•gcdaxcre
re•onaxcre

5r.my3.avry 2tA3r1eUENh.eAth
Fungalg igfecgttgeoaseok,gnuhgolg igfocgtgaa
1. AtacAhmAenmtn2aEnrmyAntyhdmNahmwah.c. hAtvcA.tmacAv. d1. Atac
i.Amy rnthA..romsa3macAmUatA23m. m1gartn .cnUA.th4mUatA23m. mTgNfmtncnUA.thdhm1
f.mAtnaAmU.hAgUatAysmeans.ttealndenAaA.2nErcy
DufmrvhAyt5a cnhomv ctnahnmv mV•ma rmv mh.snmcahnhma lv am•rynmA.mwah.c. hAtvcAv. •o
enaracen4mrv••v nhhomr3hte3Aesvahd
1dNywcyEyvy. c
Dvwn m.ta2234mvdsdm.tmvdwdm aUvrm. hnAm.-macAv. dmBytaAv. pmIf…ed1icosAc wio3nAU










???




?

?

?????
€
?

?

???????




…




???????

?

5r.my3.avry 2tA3r1eUENh.eAth
Fungalg igfecgttgeoaseok,gnuhgolg igfocgtgaa
1. AtacAhmAenmtn2aEnrmyAntyhdmNahmwah.c. hAtvcA.tmacAv. d1. Atac
i.Amy rnthA..romsa3macAmUatA23m. m1gartn .cnUA.th4mUatA23m. mTgNfmtncnUA.thdhm1
f.mAtnaAmU.hAgUatAysmeans.ttealndenAaA.2nErcy
DufmrvhAyt5a cnhomv ctnahnmv mV•ma rmv mh.snmcahnhma lv am•rynmA.mwah.c. hAtvcAv. •o
enaracen4mrv••v nhhomr3hte3Aesvahd
1dNywcyEyvy. c
Dvwn m.ta2234mvdsdm.tmvdwdm aUvrm. hnAm.-macAv. dmBytaAv. pmIf…ed1icosAc wio3nAU










???




?

?

?????
€
?

?

???????




…




???????

?

wygnyayirsiegpgnaicrpeEoxaoythvPadracg’rpaioaoh--vrsrpeEoxaeta-)rcpipeaAtsrpaipPaAy kngc‘ipisclst-uaulc‘-FFi(b
Firrst-g-tenaoi
Firrst-srge-nFi
ao
 -ie(ir‘-(Ti-ygpc-se-(Ti-
psi(l-s‘-tge’ir(ip-se-(Ti-u)S-se(g-dirrgA‘-
srge-nFi
+o l-vTstT-s‘-my‘gryip-se(g-(Ti-
fAtg‘mh-tihh‘-yc-mt(s’i-(rme‘zgr(-mep-
drgf-(Tieti-se(g-(Ti-zhm‘fm--
)e-(Ti-zhm‘fml-srge-s‘-ygAep-(g-
(rme‘dirrse-mep-fg‘(-s‘-A‘ip--
se-ryt-,ieirm(sge-se-(Ti-
-ygei-fmrrgv
awf,
awf,
)rge-s‘-‘(grip-m‘-dirrs(se-gr-Tmifg‘spirsel-fmsehc-se-fgegeAthimr-zTm,gtc(i‘-nfez -mep-hs’ir
+Ef,+Ef,
STi-ygpc-tmeeg(-ixtri(i-srge-yA(-Pf,-zir-pmc-s‘-hg‘(-fmsehc-
(TrgA,T-‘hgA,Tse,-gd-dirrs(sektge(msese,-u)S-fAtg‘mh-tihh‘
bf,
Dgei-fmrrgv2----------------
se-ryt-zritAr‘gr‘-
nPffwf, 
Lowerwso wbldddguc
ƒan w(ce bsebsM  i
HTms(owsik.
‚Tm
AennPonslH‚)Tmu
„c wonsebssTb(
slH)))Tmuss
…2knTkslfTmu
lyw bsens(wonobcsebsT. m2 aebIsebsr.c rtw Tonskbis ctowsob†.Tonu
-o

‚ƒ„…p017 5hH• D0
R&D 7e Ch 50, p 663; D&H 2e Ch 34, p 116
R&DD 7eCh750e&Dh7,0p5 70,7R&D 7eCh 50,pDe63D,; 6R&D 7eC
h5R
 

0, e &p,63C;
 H;; p,e& 663
  ­
RH2;4C;6;1;&DC
  
€
7‚C673&4&1H0Dh7C1 7D042hp71 e&0467

wygnyayirsiegpgnaicrpeEoxaoythvPadracg’rpaioaoh--vrsrpeEoxaeta-)rcpipeaAtsrpaipPaAy kngc‘ipisclst-uaulc‘-FFi(b
Firrst-g-tenaoi
Firrst-srge-nFi
ao
 -ie(ir‘-(Ti-ygpc-se-(Ti-
psi(l-s‘-tge’ir(ip-se-(Ti-u)S-se(g-dirrgA‘-
srge-nFi
+o l-vTstT-s‘-my‘gryip-se(g-(Ti-
fAtg‘mh-tihh‘-yc-mt(s’i-(rme‘zgr(-mep-
drgf-(Tieti-se(g-(Ti-zhm‘fm--
)e-(Ti-zhm‘fml-srge-s‘-ygAep-(g-
(rme‘dirrse-mep-fg‘(-s‘-A‘ip--
se-ryt-,ieirm(sge-se-(Ti-
-ygei-fmrrgv
awf,
awf,
)rge-s‘-‘(grip-m‘-dirrs(se-gr-Tmifg‘spirsel-fmsehc-se-fgegeAthimr-zTm,gtc(i‘-nfez -mep-hs’ir
+Ef,+Ef,
STi-ygpc-tmeeg(-ixtri(i-srge-yA(-Pf,-zir-pmc-s‘-hg‘(-fmsehc-
(TrgA,T-‘hgA,Tse,-gd-dirrs(sektge(msese,-u)S-fAtg‘mh-tihh‘
bf,
Dgei-fmrrgv2----------------
se-ryt-zritAr‘gr‘-
nPffwf, 
Lowerwso wbldddguc
ƒan w(ce bsebsM  i
HTms(owsik.
‚Tm
AennPonslH‚)Tmu
„c wonsebssTb(
slH)))Tmuss
…2knTkslfTmu
lyw bsens(wonobcsebsT. m2 aebIsebsr.c rtw Tonskbis ctowsob†.Tonu
-o

‚ƒ„…p017 5hH• D0
R&D 7e Ch 50, p 663; D&H 2e Ch 34, p 116
R&DD 7eCh750e&Dh7,0p5 70,7R&D 7eCh 50,pDe63D,; 6R&D 7eC
h5R
 

0, e &p,63C;
 H;; p,e& 663
  ­
RH2;4C;6;1;&DC
  
€
7‚C673&4&1H0Dh7C1 7D042hp71 e&0467

Patien srd srdonoatien s ih-c
uamesa.-ehdTesmemdT
ktamesesmeldy
Antgf
Patien srdsto shrnt-riscngschternbsrdstol-regsor-urn sblbt u
Patienie asrdioho-csrg
aeiberoluPm.T
kiensiohsr
yrnoiseil sn‘sn-it
Patienie asr
mol-reg
P
u
P

Ppon-Sehscble1lI-iSeatfi-noc,l
 ienosrc,l1-n2lPS-c-hlbon-SehsIli-no
.t ena-h-b‘c
Patiesf
laeiberoc
. Trtol-rken 
-Incler
ioho-coc
sclioho-cof
unasIqoilhsroclbo-r
gio-noil4‘-rnsntT
(-iSsb-)eho

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&MLCKa2+GAsc
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh13,p6138
-
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis
•govyish)yi(g•
e,nuncxv
6,•
0••
etvvxghdncnGg
ly)t)gT(twgh hyihbhB
Tntohn-gigo(
•Ttoy(,nunct)h(in)(
h;•&h
€h;&h;•&h3Ch
dyivnuh,yio
‚y)xvh)gixugxv









 
 
 
­
­€€‚
ƒ „
­€…€‚
­
€
€

 †

‚„ ‚€
‚†‚
‡ˆ†

‰‚ 

Patien srd srdonoatien s ih-c
uamesa.-ehdTesmemdT
ktamesesmeldy
Antgf
Patien srdsto shrnt-riscngschternbsrdstol-regsor-urn sblbt u
Patienie asrdioho-csrg
aeiberoluPm.T
kiensiohsr
yrnoiseil sn‘sn-it
Patienie asr
mol-reg
P
u
P

Ppon-Sehscble1lI-iSeatfi-noc,l
 ienosrc,l1-n2lPS-c-hlbon-SehsIli-no
.t ena-h-b‘c
Patiesf
laeiberoc
. Trtol-rken 
-Incler
ioho-coc
sclioho-cof
unasIqoilhsroclbo-r
gio-noil4‘-rnsntT
(-iSsb-)eho

R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&MLCKa2+GAsc
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh13,p6138
-
lgiwghtofnccn(tyohk),gcy togv
.gv)godtoG
oyindigogiGt)
to,tIt(tyo
.gv)godtoG
vgiy(yogiGt)k
go gT,nutogiGt)
to,tIt(tyo
lgxiyTn(,t)hTnto
zux(ncn(gk
vxIv(no)ghp
piyv(nGunodtov
•,R,
go gT,nuto
•Ttonuh)yid
R&DCh
pgitT,gis
•govyish)yi(g•
e,nuncxv
6,•
0••
etvvxghdncnGg
ly)t)gT(twgh hyihbhB
Tntohn-gigo(
•Ttoy(,nunct)h(in)(
h;•&h
€h;&h;•&h3Ch
dyivnuh,yio
‚y)xvh)gixugxv









 
 
 
­
­€€‚
ƒ „
­€…€‚
­
€
€

 †

‚„ ‚€
‚†‚
‡ˆ†

‰‚ 















 ­

€‚

•LLLoL•€g•kkokv D.gkmoLkk,LL
fbupbko
fbu
pkobLkD.DfbgLDbDbbLumDvooD,D.hCvv
bLvfbD,gLulD,gLLDbvvv,DDD,
LL.DvbDLDD.vfbEouhbDk,oDbvD
•u.uD.D•u•••u
fb•kDuku g-•DulD,DoLDDfbvbbD• DD
DD•DvL€vbv,fDbDkD,LD,DDfDbDu
ufpfkoLmD.DDv‚,bvDfoDƒLk,fb„D.Df.D,
,bvDbkDDuCbffDv••bffD,LbD.
DbDbfu
D.LLkLgL…D†bof,vDu

?







   
?
­   
€ ‚ƒ„

+–disdplpdace NdilA2cAAc–l2.

Smoth us
βα
Smotho u oscl
 idce–NcA2
βα
cl
β

βα
 NAe




Smoth ushmcltetsh
NA2 is1Ai sdp
+
+
+
+
1piAl 
1piAl 
Smoth musoc
pe isp–dNAec
2–dlepe ad
+
+
1peAadadc


1lep–lNAec displace NA
Smoth u



+

+
dc s
+
+
p–l2sda2NA

β
2
α
1
β
1
Smooth muscle cell S SS
↑β



+




Smoth uscl

R&,5&D 505e 50,pe63,Ch5h50
R&D 7eCh&570,pR&D 7eCDh50, p&6 3;,H&26&2;40h1C7 

6 ,750p


3;6
R&D 7eCh570,p 

 ­€‚ ƒ
HC707 eCh2pD
„  …†
‡ˆ ‰ 
Š
641DpDhDD ,p
„
‹
‚   
Œ Ž
‹
 ‚ ; 

???


fb
ufpfkoL
D.LLkLgL

fbuuubpkboLDbb.
gbfmbbmbmbmofmbLbmfbmvLf,fLbfbmfmbfL
vLmfbbpfLbhbmfmbmbmCfLbvmLbLfLmbfLboLDblf
gbfmbf


 
­
????
…†‡ˆ
‡ˆ
‰­Š
‡

Simple dpagraogodm ldif dpagpbgolfsmyi f‘fidfgidiroSimtW
Simple diagram of absorption and distribution of a drug
What is meant by the term ‘bioavailability’?
Passage across the
blood–brain barrier
Absorption across the
mucosa of the intestine 
Passive reabsorption
from the renal tubules
Penetration
into cells
Drug administration Drug eliminationDrug in plasma
Drug in peripheral
tissues
Drug in brain
Lipid solubility
and ionisation
Routes of
administration
Lipid solubility
and ionisation







f••••••
•••f•• •

• • 
-•f• •€‚
ƒ„…†

G-protrerinNCiN5pt n5b5ordtgdwastbim5lrpr5ei1G-prot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
7
ibn5oopdei -CsiToeTlp

????
??
???
inG
? ??
?? ?
???????? ?
? ?? ????
NCrtr-5CHTe 
? ????
??

Gbd ge H w -pe
???
?? ??
??????
?
?
GaesmrepgaslCr1
? ?
?
7
? ?
?
7
?
7
?
7
?
7
α
β β

To

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o

G-protrerinNCiN5pt 35b5ordtgdwastoil-4wm5lrpr5ei6td-m5lrpr5ei1HT -btot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
b
ibn5oopdei -CsiToeTlp
ffmm)uffmm)f/RfT)fx
T/mu••(u•••m/TxP
tnpidC3p-iN•iTob-p5epeiTCoTe5tTCoiC itnpi3p5ad i25eTbidCb5d
5o5petnptTbi••-•g
inG
€ ‚
ƒ   
NCrtr-5CHTe 
­ „ƒ …­
-CNTr5b5Topidpeeib5-lTCtC…Tbg•
Gbd ge H w -pe
†  ‡ˆ‰ 
   † 
­†
‰gˆ
iŠ‹Œng
GaesmrepgaslCr1
Ž ‘

7
Ž 
wi7i•
7
iiiiiw•
7
wi7i•
7
iiiiiw•
7
α
β β

To















 ­

€‚

•LLLoL•€g•kkokv D.gkmoLkk,LL
fbupbko
fbu
pkobLkD.DfbgLDbDbbLumDvooD,D.hCvv
bLvfbD,gLulD,gLLDbvvv,DDD,
LL.DvbDLDD.vfbEouhbDk,oDbvD
•u.uD.D•u•••u
fb•kDuku g-•DulD,DoLDDfbvbbD• DD
DD•DvL€vbv,fDbDkD,LD,DDfDbDu
ufpfkoLmD.DDv‚,bvDfoDƒLk,fb„D.Df.D,
,bvDbkDDuCbffDv••bffD,LbD.
DbDbfu
D.LLkLgL…D†bof,vDu

?







   
?
­   
€ ‚ƒ„

+–disdplpdace NdilA2cAAc–l2.

Smoth us
βα
Smotho u oscl
 idce–NcA2
βα
cl
β

βα
 NAe




Smoth ushmcltetsh
NA2 is1Ai sdp
+
+
+
+
1piAl 
1piAl 
Smoth musoc
pe isp–dNAec
2–dlepe ad
+
+
1peAadadc


1lep–lNAec displace NA
Smoth u



+

+
dc s
+
+
p–l2sda2NA

β
2
α
1
β
1
Smooth muscle cell S SS
↑β



+




Smoth uscl

R&,5&D 505e 50,pe63,Ch5h50
R&D 7eCh&570,pR&D 7eCDh50, p&6 3;,H&26&2;40h1C7 

6 ,750p


3;6
R&D 7eCh570,p 

 ­€‚ ƒ
HC707 eCh2pD
„  …†
‡ˆ ‰ 
Š
641DpDhDD ,p
„
‹
‚   
Œ Ž
‹
 ‚ ; 















 ­

€‚

•LLLoL•€g•kkokv D.gkmoLkk,LL
fbupbko
fbu
pkobLkD.DfbgLDbDbbLumDvooD,D.hCvv
bLvfbD,gLulD,gLLDbvvv,DDD,
LL.DvbDLDD.vfbEouhbDk,oDbvD
•u.uD.D•u•••u
fb•kDuku g-•DulD,DoLDDfbvbbD• DD
DD•DvL€vbv,fDbDkD,LD,DDfDbDu
ufpfkoLmD.DDv‚,bvDfoDƒLk,fb„D.Df.D,
,bvDbkDDuCbffDv••bffD,LbD.
DbDbfu
D.LLkLgL…D†bof,vDu

?







   
?
­   
€ ‚ƒ„

+–disdplpdace NdilA2cAAc–l2.

Smoth us
βα
Smotho u oscl
 idce–NcA2
βα
cl
β

βα
 NAe




Smoth ushmcltetsh
NA2 is1Ai sdp
+
+
+
+
1piAl 
1piAl 
Smoth musoc
pe isp–dNAec
2–dlepe ad
+
+
1peAadadc


1lep–lNAec displace NA
Smoth u



+

+
dc s
+
+
p–l2sda2NA

β
2
α
1
β
1
Smooth muscle cell S SS
↑β



+




Smoth uscl

R&,5&D 505e 50,pe63,Ch5h50
R&D 7eCh&570,pR&D 7eCDh50, p&6 3;,H&26&2;40h1C7 

6 ,750p


3;6
R&D 7eCh570,p 

 ­€‚ ƒ
HC707 eCh2pD
„  …†
‡ˆ ‰ 
Š
641DpDhDD ,p
„
‹
‚   
Œ Ž
‹
 ‚ ; 

???


fb
ufpfkoL
D.LLkLgL

fbuuubpkboLDbb.
gbfmbbmbmbmofmbLbmfbmvLf,fLbfbmfmbfL
vLmfbbpfLbhbmfmbmbmCfLbvmLbLfLmbfLboLDblf
gbfmbf


 
­
????
…†‡ˆ
‡ˆ
‰­Š
‡

???


fb
ufpfkoL
D.LLkLgL

fbuuubpkboLDbb.
gbfmbbmbmbmofmbLbmfbmvLf,fLbfbmfmbfL
vLmfbbpfLbhbmfmbmbmCfLbvmLbLfLmbfLboLDblf
gbfmbf


 
­
????
…†‡ˆ
‡ˆ
‰­Š
‡

Simple dpagraogodm ldif dpagpbgolfsmyi f‘fidfgidiroSimtW
Simple diagram of absorption and distribution of a drug
What is meant by the term ‘bioavailability’?
Passage across the
blood–brain barrier
Absorption across the
mucosa of the intestine 
Passive reabsorption
from the renal tubules
Penetration
into cells
Drug administration Drug eliminationDrug in plasma
Drug in peripheral
tissues
Drug in brain
Lipid solubility
and ionisation
Routes of
administration
Lipid solubility
and ionisation

Simple dpagraogodm ldif dpagpbgolfsmyi f‘fidfgidiroSimtW
Simple diagram of absorption and distribution of a drug
What is meant by the term ‘bioavailability’?
Passage across the
blood–brain barrier
Absorption across the
mucosa of the intestine 
Passive reabsorption
from the renal tubules
Penetration
into cells
Drug administration Drug eliminationDrug in plasma
Drug in peripheral
tissues
Drug in brain
Lipid solubility
and ionisation
Routes of
administration
Lipid solubility
and ionisation







f••••••
•••f•• •

• • 
-•f• •€‚
ƒ„…†







f••••••
•••f•• •

• • 
-•f• •€‚
ƒ„…†

G-protrerinNCiN5pt n5b5ordtgdwastbim5lrpr5ei1G-prot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
7
ibn5oopdei -CsiToeTlp

????
??
???
inG
? ??
?? ?
???????? ?
? ?? ????
NCrtr-5CHTe 
? ????
??

Gbd ge H w -pe
???
?? ??
??????
?
?
GaesmrepgaslCr1
? ?
?
7
? ?
?
7
?
7
?
7
?
7
α
β β

To

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o

G-protrerinNCiN5pt 35b5ordtgdwastoil-4wm5lrpr5ei6td-m5lrpr5ei1HT -btot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
b
ibn5oopdei -CsiToeTlp
ffmm)uffmm)f/RfT)fx
T/mu••(u•••m/TxP
tnpidC3p-iN•iTob-p5epeiTCoTe5tTCoiC itnpi3p5ad i25eTbidCb5d
5o5petnptTbi••-•g
inG
€ ‚
ƒ   
NCrtr-5CHTe 
­ „ƒ …­
-CNTr5b5Topidpeeib5-lTCtC…Tbg•
Gbd ge H w -pe
†  ‡ˆ‰ 
   † 
­†
‰gˆ
iŠ‹Œng
GaesmrepgaslCr1
Ž ‘

7
Ž 
wi7i•
7
iiiiiw•
7
wi7i•
7
iiiiiw•
7
α
β β

To

G-protrerinNCiN5pt n5b5ordtgdwastbim5lrpr5ei1G-prot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
7
ibn5oopdei -CsiToeTlp

????
??
???
inG
? ??
?? ?
???????? ?
? ?? ????
NCrtr-5CHTe 
? ????
??

Gbd ge H w -pe
???
?? ??
??????
?
?
GaesmrepgaslCr1
? ?
?
7
? ?
?
7
?
7
?
7
?
7
α
β β

To

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o

G-protrerinNCiN5pt 35b5ordtgdwastoil-4wm5lrpr5ei6td-m5lrpr5ei1HT -btot-ei
G-protreirnNCr55rHNT HNbdrp-grNtreirnnCr5rwaa
G-prpoteitnpiN-CN5H5tTCoiC iop-rpi5btTCoiNCtpotT5degiwdCbaeies5ddmlT5sptp-iN5Toi12-pei5tidC3p-
bCobpot-5tTCoitn5oid5-Hpi12-peg
G-prote
4epmlpNpolpoti2dCbaiC irCdt5HpmH5tpli65
b
ibn5oopdei -CsiToeTlp
ffmm)uffmm)f/RfT)fx
T/mu••(u•••m/TxP
tnpidC3p-iN•iTob-p5epeiTCoTe5tTCoiC itnpi3p5ad i25eTbidCb5d
5o5petnptTbi••-•g
inG
€ ‚
ƒ   
NCrtr-5CHTe 
­ „ƒ …­
-CNTr5b5Topidpeeib5-lTCtC…Tbg•
Gbd ge H w -pe
†  ‡ˆ‰ 
   † 
­†
‰gˆ
iŠ‹Œng
GaesmrepgaslCr1
Ž ‘

7
Ž 
wi7i•
7
iiiiiw•
7
wi7i•
7
iiiiiw•
7
α
β β

To

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o



























DbDfDfE
//fDfDfS
g•

mfE
ff•••fS
g•
mfE
mD•/fE
DbDfDfE
Db/f•S
••

• 
-
Db/f•S
DbDfDfE
DmD
/fS
•€
-
••
-
•D
m
g

mfEb•DE
ff•••fS








 ­€‚
ƒ

„…‚ †‡ 
­

ˆ‰

Œ Ž

phsfrfhtffhthld
The mo st uf l dfun ehi st ‘f ll ’f.’d
The most useful defnition is ‘Se cardadrS1d6cd.cSe c02i161bS r 2c2db cSe0Scr 0ue bcSe cbpbS i1ucu1ruof0S1d6’.
Incomplete release from the dosage form, destruction within the gut, poor absorption and frst-pass elimination 
are important causes of low bioavailability. For drugs with a low therapeutic index it is important that repeat 
prescriptions provide medicines of equivalent bioavailability (bioequivalence).
n0rS10fc0,bdraS1d6
-Low lipid solubility.
-Ionisation.
-Complexation with
 gut contents (e.g.
 tetracycline/Ca
2+ salts)
-Rapid loss from gut
(diarrhoea).
s bSrouS1d6c16ctoSm
Peptides and proteins
subject to proteolytic
enzymes. Some drugs
acid labile.
l S0,df1bic,pctoScioudb0
drcf1C rc16cxhrbSca0bb:T
90% or more of a drug
dose may be metabolised
during its frst passage
through the liver.
Only a fraction of
dose may reach
general circulation
srotc.driof0S1d6: the
main factor determining
diferences between
preparations.
Drug in solution
in the gut
Disintegration and
dissolution of tablet
s10tr0icbedX16tc.0uSdrbc16Ao 6u16tc,1d0C01f0,1f1Sp

?
































R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&Goboh,nfdnAscƒ
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
prexrfn,TtmmtInb,fuNcrmbdn,rS
srSNr,hn,A
,bether,reAnN
n,cnGnInb,
srSNr,hn,A
SrebIb,reAnNu
r,drRctgn,reAnN
n,cnGnInb,
prvebRtIcnNfRtn,
CgvItmtIru
SvGSIt,Nrfl
lebSItAgt,hn,S
•,R,
r,drRctgn,
fRn,tgfNbeh
R&DCh
lrenRcrei

Pethidine, fentanyl
Pethidine, fentanyl
Methadone,
propoxyphene
Methadone,
propoxyphene
Tramadol
Tramadol
Ibuprofen
Naloxone Morphine, diamorphine,
buprenorphine, codeine
Sensory cortex
Thalamus
PAG
NRM
Tissue damage
Nociceptive C or A B
pain aferent
Spinothalamic tract
neuron
Interneuron in
dorsal horn
Morphine, diamorphine,
buprenorphine, codeine
Amitriptyline
Carbamazepine
Locus ceruleus

R&D 7 eCh5C,p&D6pC0&0 7&,R&D?
R&D 7eCh5, &p,h68hC&1;&H,82D&,4;e 5,14&1;&h&ChCCh0,h4& e00
R&D 77eCh5,p7
6&D8p71;
D epHD&&&D




?
eCHD;p7h,
?
;p7h,D
?
?
?????
???????
???????
??????
?????
??????
?D?????
?D?????
??D?????
?????
R , 01H,8D ˆ-•‰

+Acts Ason,anueg sos umgegv+Aci
+Actsc on,oaueo cAgoacsteaio,nsocgaAvcgvesorsMtoauescm–o
+Actst ton,aAouenata
gtivorMmnvut na
–nvActivorMmnvut na
oAsna
+rcton,aAouenata

ucoanc,snaanonc,ctivavsm
g
+cvuntoa gnMnuvca
•tMcvurirmna
•tamuto,Mcvaa•
mto•a,– ,auco a
–vnmunimuc Are
touncMmuna,•,Mcvaa•mto•a
•mnvsAMto
 sna,–
 mrvcvrcMtm,toetitua
 -•+,aAouenata
+nouvauuto
sncMuvrcton
toetitu,rcton,•,ctiv•
orMmnvut n,aAouenata
•nuevucnun
toetitua,rcton,aAouenata,
o , -•+,aAouenata
•Auciton
toetitua,– ,aAouenata

“ogfƒ‹bmvof,ffgbhoggfE••D.oD.E
fbu


fb
ufpfkoL
D.LLkLgL







  
­ €‚
ƒ „

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o

G-protrerinNCiN5pnHT -btot-eiG-pH2
G-protrerinNCiN5pntHrTt itrbH5e5nNidibt5etrtgrd5iNTt-wtarTntN-tdibspitNCitNdrenH5nn5-et-wtmr5etN-tNCitl123
G-prote
oioenNCen5o
GH5ioT
oioenNCen5o
 epNebpo
d-pogwoNep
apotCis5mgwoNep
li1TNpoN5si
oioenNCen5o
G-prot-einNC5GH
G-prot-ei G-prot-ei G-prot-ei
G-prot-ei
Geinsp2
iep3e
4ep3e
bTst6
7H5m-poT
oioenNCen5o



























DbDfDfE
//fDfDfS
g•

mfE
ff•••fS
g•
mfE
mD•/fE
DbDfDfE
Db/f•S
••

• 
-
Db/f•S
DbDfDfE
DmD
/fS
•€
-
••
-
•D
m
g

mfEb•DE
ff•••fS








 ­€‚
ƒ

„…‚ †‡ 
­

ˆ‰

Œ Ž



























DbDfDfE
//fDfDfS
g•

mfE
ff•••fS
g•
mfE
mD•/fE
DbDfDfE
Db/f•S
••

• 
-
Db/f•S
DbDfDfE
DmD
/fS
•€
-
••
-
•D
m
g

mfEb•DE
ff•••fS








 ­€‚
ƒ

„…‚ †‡ 
­

ˆ‰

Œ Ž

phsfrfhtffhthld
The mo st uf l dfun ehi st ‘f ll ’f.’d
The most useful defnition is ‘Se cardadrS1d6cd.cSe c02i161bS r 2c2db cSe0Scr 0ue bcSe cbpbS i1ucu1ruof0S1d6’.
Incomplete release from the dosage form, destruction within the gut, poor absorption and frst-pass elimination 
are important causes of low bioavailability. For drugs with a low therapeutic index it is important that repeat 
prescriptions provide medicines of equivalent bioavailability (bioequivalence).
n0rS10fc0,bdraS1d6
-Low lipid solubility.
-Ionisation.
-Complexation with
 gut contents (e.g.
 tetracycline/Ca
2+ salts)
-Rapid loss from gut
(diarrhoea).
s bSrouS1d6c16ctoSm
Peptides and proteins
subject to proteolytic
enzymes. Some drugs
acid labile.
l S0,df1bic,pctoScioudb0
drcf1C rc16cxhrbSca0bb:T
90% or more of a drug
dose may be metabolised
during its frst passage
through the liver.
Only a fraction of
dose may reach
general circulation
srotc.driof0S1d6: the
main factor determining
diferences between
preparations.
Drug in solution
in the gut
Disintegration and
dissolution of tablet
s10tr0icbedX16tc.0uSdrbc16Ao 6u16tc,1d0C01f0,1f1Sp

phsfrfhtffhthld
The mo st uf l dfun ehi st ‘f ll ’f.’d
The most useful defnition is ‘Se cardadrS1d6cd.cSe c02i161bS r 2c2db cSe0Scr 0ue bcSe cbpbS i1ucu1ruof0S1d6’.
Incomplete release from the dosage form, destruction within the gut, poor absorption and frst-pass elimination 
are important causes of low bioavailability. For drugs with a low therapeutic index it is important that repeat 
prescriptions provide medicines of equivalent bioavailability (bioequivalence).
n0rS10fc0,bdraS1d6
-Low lipid solubility.
-Ionisation.
-Complexation with
 gut contents (e.g.
 tetracycline/Ca
2+ salts)
-Rapid loss from gut
(diarrhoea).
s bSrouS1d6c16ctoSm
Peptides and proteins
subject to proteolytic
enzymes. Some drugs
acid labile.
l S0,df1bic,pctoScioudb0
drcf1C rc16cxhrbSca0bb:T
90% or more of a drug
dose may be metabolised
during its frst passage
through the liver.
Only a fraction of
dose may reach
general circulation
srotc.driof0S1d6: the
main factor determining
diferences between
preparations.
Drug in solution
in the gut
Disintegration and
dissolution of tablet
s10tr0icbedX16tc.0uSdrbc16Ao 6u16tc,1d0C01f0,1f1Sp

?
































R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&Goboh,nfdnAscƒ
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
prexrfn,TtmmtInb,fuNcrmbdn,rS
srSNr,hn,A
,bether,reAnN
n,cnGnInb,
srSNr,hn,A
SrebIb,reAnNu
r,drRctgn,reAnN
n,cnGnInb,
prvebRtIcnNfRtn,
CgvItmtIru
SvGSIt,Nrfl
lebSItAgt,hn,S
•,R,
r,drRctgn,
fRn,tgfNbeh
R&DCh
lrenRcrei

Pethidine, fentanyl
Pethidine, fentanyl
Methadone,
propoxyphene
Methadone,
propoxyphene
Tramadol
Tramadol
Ibuprofen
Naloxone Morphine, diamorphine,
buprenorphine, codeine
Sensory cortex
Thalamus
PAG
NRM
Tissue damage
Nociceptive C or A B
pain aferent
Spinothalamic tract
neuron
Interneuron in
dorsal horn
Morphine, diamorphine,
buprenorphine, codeine
Amitriptyline
Carbamazepine
Locus ceruleus

R&D 7 eCh5C,p&D6pC0&0 7&,R&D?
R&D 7eCh5, &p,h68hC&1;&H,82D&,4;e 5,14&1;&h&ChCCh0,h4& e00
R&D 77eCh5,p7
6&D8p71;
D epHD&&&D




?
eCHD;p7h,
?
;p7h,D
?
?
?????
???????
???????
??????
?????
??????
?D?????
?D?????
??D?????
?????
R , 01H,8D ˆ-•‰

+Acts Ason,anueg sos umgegv+Aci
+Actsc on,oaueo cAgoacsteaio,nsocgaAvcgvesorsMtoauescm–o
+Actst ton,aAouenata
gtivorMmnvut na
–nvActivorMmnvut na
oAsna
+rcton,aAouenata

ucoanc,snaanonc,ctivavsm
g
+cvuntoa gnMnuvca
•tMcvurirmna
•tamuto,Mcvaa•
mto•a,– ,auco a
–vnmunimuc Are
touncMmuna,•,Mcvaa•mto•a
•mnvsAMto
 sna,–
 mrvcvrcMtm,toetitua
 -•+,aAouenata
+nouvauuto
sncMuvrcton
toetitu,rcton,•,ctiv•
orMmnvut n,aAouenata
•nuevucnun
toetitua,rcton,aAouenata,
o , -•+,aAouenata
•Auciton
toetitua,– ,aAouenata

“ogfƒ‹bmvof,ffgbhoggfE••D.oD.E
fbu


fb
ufpfkoL
D.LLkLgL







  
­ €‚
ƒ „

?
































R&D 7eCh24,p37C4D&,40;e42H&0pH 4H548Dh&Goboh,nfdnAscƒ
R&D 7&eCh2h&4,p4D2302 4&;2 4H584-20p3D2 Cp& 5Cp-2H329p4&;
R&D 7eChCh24,p3240
;
prexrfn,TtmmtInb,fuNcrmbdn,rS
srSNr,hn,A
,bether,reAnN
n,cnGnInb,
srSNr,hn,A
SrebIb,reAnNu
r,drRctgn,reAnN
n,cnGnInb,
prvebRtIcnNfRtn,
CgvItmtIru
SvGSIt,Nrfl
lebSItAgt,hn,S
•,R,
r,drRctgn,
fRn,tgfNbeh
R&DCh
lrenRcrei

Pethidine, fentanyl
Pethidine, fentanyl
Methadone,
propoxyphene
Methadone,
propoxyphene
Tramadol
Tramadol
Ibuprofen
Naloxone Morphine, diamorphine,
buprenorphine, codeine
Sensory cortex
Thalamus
PAG
NRM
Tissue damage
Nociceptive C or A B
pain aferent
Spinothalamic tract
neuron
Interneuron in
dorsal horn
Morphine, diamorphine,
buprenorphine, codeine
Amitriptyline
Carbamazepine
Locus ceruleus

R&D 7 eCh5C,p&D6pC0&0 7&,R&D?
R&D 7eCh5, &p,h68hC&1;&H,82D&,4;e 5,14&1;&h&ChCCh0,h4& e00
R&D 77eCh5,p7
6&D8p71;
D epHD&&&D




?
eCHD;p7h,
?
;p7h,D
?
?
?????
???????
???????
??????
?????
??????
?D?????
?D?????
??D?????
?????
R , 01H,8D ˆ-•‰

+Acts Ason,anueg sos umgegv+Aci
+Actsc on,oaueo cAgoacsteaio,nsocgaAvcgvesorsMtoauescm–o
+Actst ton,aAouenata
gtivorMmnvut na
–nvActivorMmnvut na
oAsna
+rcton,aAouenata

ucoanc,snaanonc,ctivavsm
g
+cvuntoa gnMnuvca
•tMcvurirmna
•tamuto,Mcvaa•
mto•a,– ,auco a
–vnmunimuc Are
touncMmuna,•,Mcvaa•mto•a
•mnvsAMto
 sna,–
 mrvcvrcMtm,toetitua
 -•+,aAouenata
+nouvauuto
sncMuvrcton
toetitu,rcton,•,ctiv•
orMmnvut n,aAouenata
•nuevucnun
toetitua,rcton,aAouenata,
o , -•+,aAouenata
•Auciton
toetitua,– ,aAouenata

“ogfƒ‹bmvof,ffgbhoggfE••D.oD.E
fbu


fb
ufpfkoL
D.LLkLgL







  
­ €‚
ƒ „
Tags